<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30627085</article-id>
<article-id pub-id-type="pmc">6309163</article-id>
<article-id pub-id-type="doi">10.3389/fncel.2018.00470</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Synaptopathology Involved in Autism Spectrum Disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Guang</surname>
<given-names>Shiqi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/588649/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pang</surname>
<given-names>Nan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deng</surname>
<given-names>Xiaolu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Lifen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Fang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Liwen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Chen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/553628/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yin</surname>
<given-names>Fei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/553855/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peng</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/553854/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Pediatrics, Xiangya Hospital, Central South University</institution>, <addr-line>Changsha</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Hunan Intellectual and Developmental Disabilities Research Center</institution>, <addr-line>Changsha</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Xiaohong Li, Institute for Basic Research in Developmental Disabilities (IBR), United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Dilja Krueger-Burg, Max-Planck-Institut für Experimentelle Medizin, Germany; Richard J. Weinberg, University of North Carolina at Chapel Hill, United States</p>
</fn>
<corresp id="c001">*Correspondence: Fei Yin, <email>yf2323@hotmail.com</email> Jing Peng, <email>pengjing4346@163.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>12</volume>
<elocation-id>470</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>11</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Guang, Pang, Deng, Yang, He, Wu, Chen, Yin and Peng.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Guang, Pang, Deng, Yang, He, Wu, Chen, Yin and Peng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Autism spectrum disorder (ASD) encompasses a group of multifactorial neurodevelopmental disorders characterized by impaired social communication, social interaction and repetitive behaviors. ASD affects 1 in 59 children, and is about 4 times more common among boys than among girls. Strong genetic components, together with environmental factors in the early stage of development, contribute to the pathogenesis of ASD. Multiple studies have revealed that mutations in genes like <italic>NRXN, NLGN</italic>, <italic>SHANK</italic>, <italic>TSC1/2</italic>, <italic>FMR1</italic>, and <italic>MECP2</italic> converge on common cellular pathways that intersect at synapses. These genes encode cell adhesion molecules, scaffolding proteins and proteins involved in synaptic transcription, protein synthesis and degradation, affecting various aspects of synapses including synapse formation and elimination, synaptic transmission and plasticity. This suggests that the pathogenesis of ASD may, at least in part, be attributed to synaptic dysfunction. In this article, we will review major genes and signaling pathways implicated in synaptic abnormalities underlying ASD, and discuss molecular, cellular and functional studies of ASD experimental models.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>ASD</kwd>
<kwd>synapse</kwd>
<kwd>synaptogenesis</kwd>
<kwd>synapse elimination</kwd>
<kwd>synaptic transmission</kwd>
<kwd>synaptic plasticity</kwd>
</kwd-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="221"></ref-count>
<page-count count="16"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>The term “autism” as a unique disease concept was first used by Leo Kanner in 1943. He described eight boys and three girls, aged two to eight, who were unable to use language to communicate, displaying monotonous repetitions and preoccupation with objects (<xref ref-type="bibr" rid="B98">Kanner, 1995</xref>). Then in 1944, Hans Asperger identified a group of children who could not integrate into their social environment and showed certain stereotypic behaviors, but did not have the speech deficiency of typical autism (<xref ref-type="bibr" rid="B83">Hippler and Klicpera, 2003</xref>). In recent years, the term autism spectrum disorder (ASD) has gained general acceptance to describe a set of multifactorial neurodevelopmental disorders, grouping disorders including autistic disorder, Asperger Syndrome, pervasive developmental disorder-not otherwise specified (PDD-NOS) and child disintegrative disorder under the umbrella ASD. Although ASD has diverse behavioral manifestations with varying degrees of severity, it has a core dyad of impairments: (1) impaired social communication and social interaction, and (2) restricted and repetitive behavior, interests or activities. There are also a number of comorbidities associated with ASD, including intellectual disability (ID), epilepsy (<xref ref-type="bibr" rid="B191">Tuchman et al., 2010</xref>), anxiety, attention deficits hyperactivity disorder (ADHD), sleeping disorders, and gastrointestinal disorders (<xref ref-type="bibr" rid="B54">Doshi-Velez et al., 2014</xref>). ASD affects 1 in 59 children in the United States, and is about 4 times more common among boys than among girls according to the estimate from CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network (<xref ref-type="bibr" rid="B8">Baio et al., 2018</xref>). Large-scale surveys show the median worldwide prevalence of ASD is 1–2% (<xref ref-type="bibr" rid="B101">Kim et al., 2011</xref>; <xref ref-type="bibr" rid="B16">Blumberg et al., 2013</xref>). ASD represents a lifelong condition for patients and many of them require special educational and social support, so ASD imposes a huge financial and emotional burden on society (<xref ref-type="bibr" rid="B107">Lavelle et al., 2014</xref>; <xref ref-type="bibr" rid="B110">Leigh and Du, 2015</xref>). However, only limited treatment of ASD is available, in part because the causes of ASD have not yet been clearly elucidated.</p>
<p>Based on current studies, strong genetic components contribute to the pathogenesis of ASD, together with environmental factors in the early stage of development. Early twin studies showed that concordance of autism in monozygotic (MZ) twins (80–90%) was much higher than that in dizygotic (DZ) twins (0–10%) (<xref ref-type="bibr" rid="B64">Folstein and Rutter, 1977</xref>; <xref ref-type="bibr" rid="B156">Ritvo et al., 1985</xref>; <xref ref-type="bibr" rid="B173">Steffenburg et al., 1989</xref>; <xref ref-type="bibr" rid="B7">Bailey et al., 1995</xref>). However, these early studies have their limitations because of their small sample size, restricted follow-up time, and vicissitudes of diagnostic criteria. In recent years, multiple population-based cohort studies provide more reliable evidence for ASD genetic predisposition. The relative recurrence rate for MZ twins (153.0) is much higher than that for DZ twins (8.2) (<xref ref-type="bibr" rid="B162">Sandin et al., 2014</xref>) and estimates of the heritability of ASD range from 54% to 95% (<xref ref-type="bibr" rid="B68">Gaugler et al., 2014</xref>; <xref ref-type="bibr" rid="B162">Sandin et al., 2014</xref>; <xref ref-type="bibr" rid="B41">Colvert et al., 2015</xref>). In addition to genetic predisposition, known environmental risk factors of ASD include advancing parental (especially paternal) reproductive age (<xref ref-type="bibr" rid="B65">Gardener et al., 2009</xref>; <xref ref-type="bibr" rid="B90">Hultman et al., 2011</xref>; <xref ref-type="bibr" rid="B161">Sandin et al., 2012</xref>), complications during pregnancy (<xref ref-type="bibr" rid="B22">Brown et al., 2014</xref>; <xref ref-type="bibr" rid="B58">Estes and McAllister, 2016</xref>) and prenatal exposure to psychotropic drugs like valproic acid (VPA) (<xref ref-type="bibr" rid="B152">Rasalam et al., 2005</xref>; <xref ref-type="bibr" rid="B125">Meador et al., 2013</xref>; <xref ref-type="bibr" rid="B20">Boukhris et al., 2016</xref>).</p>
<p>Recent advances in gene testing techniques have allowed identification of more than 1,000 candidate genes and copy number variants (CNVs) loci associated with ASD, according to the Simmons Foundation Autism Research Initiative (SFARI) gene database<sup><xref ref-type="fn" rid="fn01">1</xref></sup>. It is estimated that a genetic cause can be identified in up to 25% of ASD cases, chromosomal rearrangements (encompassing rare and de novo CNVs) and coding-sequence mutations making up ∼10–20% and ∼5–10% of ASD patients, respectively (<xref ref-type="bibr" rid="B89">Huguet et al., 2013</xref>; <xref ref-type="bibr" rid="B221">Ziats and Rennert, 2016</xref>). Numerous ASD candidate genes implicated in many aspects of basic cell function such as chromatin remodeling, metabolism, mRNA translation may impact neuronal processes ranging from neurogenesis to neuron migration, axon guidance, dendrite outgrowth, and synaptic formation and function (<xref ref-type="bibr" rid="B72">Gilbert and Man, 2017</xref>).</p>
<p>Synapses are highly specialized asymmetric cell-cell junctions that are fundamental units of brain communication. ASD is diagnosed at an early stage of life, usually before three years of age, a period when intense synaptogenesis is happening (<xref ref-type="bibr" rid="B92">Huttenlocher and Dabholkar, 1997</xref>). Multiple studies have found that mutations in genes like <italic>NRXN, NLGN</italic>, <italic>SHANK</italic>, <italic>TSC1/2</italic>, <italic>FMR1</italic>, and <italic>MECP2</italic> (Table <xref ref-type="table" rid="T1">1</xref>) converge on common cellular pathways that converge at the synapse (<xref ref-type="bibr" rid="B205">Wang T. et al., 2016</xref>; <xref ref-type="bibr" rid="B174">Stessman et al., 2017</xref>). ASD patients are found to carry a higher global burden of rare, large CNVs which can include known ASD associated synaptic genes, such as <italic>SHANK3</italic> and <italic>CHD10</italic> (<xref ref-type="bibr" rid="B79">Guo et al., 2017</xref>). These genes encode cell adhesion molecules, scaffolding proteins, and proteins involved in synaptic transcription, protein synthesis and degradation, which affect various aspects of synapses, including synapse formation and elimination, synaptic transmission and plasticity, suggesting that the pathogenesis of ASD, at least in part, may be attributed to synaptic dysfunction, which can lead to functional and cognitive impairments. Some environmental risk factors of ASD can also bring about synaptic defects. For instance, the patterns of long-term potentiation (LTP) of mice that are prenatally exposed to VPA pass from an enhanced LTP phenotype in early life to an impaired LTP phenotype in adulthood (<xref ref-type="bibr" rid="B155">Rinaldi et al., 2007</xref>). Synaptic impairments caused by gene mutations and environmental factors are implicated in many other neurodevelopmental diseases including epilepsy, ID, developmental delay, and attention deficit-hyperactivity disorder (ADHD). Some neuropsychiatric disorders, including schizophrenia (SCZ), bipolar disorder and obsessive-compulsive disorder (OCD) are also associated with synaptic dysfunction. Though rare non-syndromic gene mutations only account for a small fraction of ASD cases, they provide an excellent window to better understanding the synaptic abnormalities underlying ASD. Insight has also been gained from studies of the synaptopathology of monogenic diseases such as fragile X syndrome, tuberous sclerosis complex, and Angelman syndrome that share a high comorbidity with ASD. In this article, we will review abnormalities in synaptogenesis, synaptic elimination, synaptic transmission and plasticity that are caused by mutations of a number of ASD-associated genes, to gain a better understanding of the synaptic dysfunctions underlying ASD.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Critical ASD candidate genes and major molecular functions in synapse.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<th align="left" colspan="1" rowspan="1" valign="top">Gene symbol</th>
<th align="left" colspan="1" rowspan="1" valign="top">Chromosomal Locus</th>
<th align="left" colspan="1" rowspan="1" valign="top">Protein</th>
<th align="left" colspan="1" rowspan="1" valign="top">Major molecular functions in synapses</th>
<th align="center" colspan="1" rowspan="1" valign="top">SFARI score</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cell adhesion molecules</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NRXN1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">2p16.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurexin 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic transmission, synaptic plasticity</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NRXN2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11q13.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurexin 2</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NRXN3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">14q24.3-q31.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurexin 3</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NLGN1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3q26.31</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroligin 1</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NLGN2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">17p13.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroligin 2</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NLGN3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xq13.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroligin 3</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NLGN4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xp22.32-p22.31</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroligin 4</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>NLGN4Y</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Yq11.221</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroligin 4Y</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CNTNAP2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7q35-q36.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">contactin associated protein-like 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic transmission</td>
<td align="center" colspan="1" rowspan="1" valign="top">2/S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CDH8</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">16q21</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cadherin 8</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic transmission</td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CDH11</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">16q21</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cadherin 11</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CNTN4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3p26.3-p26.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Contactin 4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis</td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CNTN6</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">3p26.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Contactin 6</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PCDH10</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4q28.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protocadherin 10</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptic elimination</td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Scaffolding proteins</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DLG4</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">17p13.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">discs large MAGUK scaffold protein 4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic elimination, synaptic plasticity</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>GPHN</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">14q23.3-24.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gephyrin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SHANK1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">19q13.33</td>
<td align="left" colspan="1" rowspan="1" valign="top">Shank 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic transmission, synaptic plasticity</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SHANK2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11q13.3-q13.4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Shank 2</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SHANK3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">22q13.33</td>
<td align="left" colspan="1" rowspan="1" valign="top">Shank 3</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1/S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HOMER1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5q14.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Homer homolog 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic plasticity</td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Regulators of protein synthesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>FMR1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xq27.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fragile mental retardation protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic transmission, synaptic elimination, synaptic plasticity</td>
<td align="center" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">and degradation</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CYFIP1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">15q11.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">cytoplasmic FMR1 interacting protein 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic transmission, synaptic plasticity</td>
<td align="center" colspan="1" rowspan="1" valign="top">3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TSC1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">9q34.13</td>
<td align="left" colspan="1" rowspan="1" valign="top">tuberous sclerosis 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic plasticity</td>
<td align="center" colspan="1" rowspan="1" valign="top">S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>TSC2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">16p13.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">tuberous sclerosis 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic plasticity</td>
<td align="center" colspan="1" rowspan="1" valign="top">3/S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>EIF4E</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4q23</td>
<td align="left" colspan="1" rowspan="1" valign="top">eukaryotic translation initiation factor 4E</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic transmission, synaptic plasticity</td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>EIF4EBP2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">10q22.1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Eukaryotic translation initiation factor 4E binding protein 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic transmission, synaptic plasticity</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PTEN</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">10q23.32</td>
<td align="left" colspan="1" rowspan="1" valign="top">phosphatase and tensin homolog</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic plasticity</td>
<td align="center" colspan="1" rowspan="1" valign="top">1/S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SYNGAP1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6p21.32</td>
<td align="left" colspan="1" rowspan="1" valign="top">synaptic Ras GTPase activating protein 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic plasticity</td>
<td align="center" colspan="1" rowspan="1" valign="top">1/S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>UBE3A</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">15q11.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">ubiquitin protein ligase E3A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic transmission, synaptic elimination</td>
<td align="center" colspan="1" rowspan="1" valign="top">3/S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Regulators of chromatin</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MECP2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xq28</td>
<td align="left" colspan="1" rowspan="1" valign="top">methyl CpG binding protein 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis, synaptic plasticity</td>
<td align="center" colspan="1" rowspan="1" valign="top">2/S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">remodeling and transcription</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>MEF2C</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5q14.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">myocyte enhancer factor 2C</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptic elimination</td>
<td align="center" colspan="1" rowspan="1" valign="top">4/S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>The SFARI score is used to evaluate the strength of association between candidate gene and ASD. (1) high confidence; (2) strong candidate; (3) suggestive evidence; (4) minimal evidence; (5) hypothesized but untested. S-syndromic genes leading to syndromes that share high comorbidity with ASD.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Cell Adhesion Molecules</title>
<sec>
<title>Neurexin/Neuroligin Complex</title>
<p>Neurexins (Nrxn) are a family of presynaptic transmembrane proteins encoded by paralogous genes, <italic>NRXN1, NRXN2, NRXN3</italic>. Each of the three genes uses 2 independent promotors to generate 2 major protein isoforms, a long α-Nrxn and a short β-Nrxn. Loss-of-function variants in <italic>NRXN1</italic> have been identified in patients with ASD in multiple cohort studies (<xref ref-type="bibr" rid="B123">Marshall et al., 2008</xref>; <xref ref-type="bibr" rid="B132">Morrow et al., 2008</xref>; <xref ref-type="bibr" rid="B75">Glessner et al., 2009</xref>). A wide spectrum of developmental disorders including ID without ASD (<xref ref-type="bibr" rid="B31">Camacho-Garcia et al., 2012</xref>; <xref ref-type="bibr" rid="B218">Yangngam et al., 2014</xref>), language delay, mild dysmorphic features, and hypotonia (<xref ref-type="bibr" rid="B36">Ching et al., 2010</xref>), as well as neuropsychiatric conditions like SCZ have also been reported in patients with <italic>NRXN1</italic> variants. In contrast, variants in <italic>NRXN2</italic> and <italic>NRXN3</italic> are much rarer, but accumulating reports provide evidence supporting an association between these two genes and ASD, as well as other neurodevelopmental and neuropsychiatric conditions (<xref ref-type="bibr" rid="B69">Gauthier et al., 2011</xref>; <xref ref-type="bibr" rid="B195">Vaags et al., 2012</xref>; <xref ref-type="bibr" rid="B219">Yuan et al., 2018</xref>).</p>
<p>Neuroligins (Nlgns), encoded by five genes (<italic>NLGN1</italic>, <italic>NLGN2</italic>, <italic>NLGN3</italic>, <italic>NLGN4</italic>, and <italic>NLGN4Y</italic>) in the human genome, are a class of cell-adhesion molecules on the postsynaptic membranes, binding to the laminin/neurexin/sex hormone (LNS) binding domain of Nrxn through the extracellular cholinesterase-like domain. Nlgn1 is expressed exclusively on excitatory synapses and binds to PSD-95, whereas Nlgn2 is restricted to inhibitory synapses, preferentially binding to gephyrin (<xref ref-type="bibr" rid="B169">Song et al., 1999</xref>; <xref ref-type="bibr" rid="B199">Varoqueaux et al., 2004</xref>). Nlgn3 and Nlgn4 are present on both types of synapses (<xref ref-type="bibr" rid="B24">Budreck and Scheiffele, 2007</xref>).</p>
<p>Nrxn binds to its postsynaptic partner Nlgn to form a Ca<sup>2+</sup>-dependent neurexin/neuroligin complex, implicated in synaptogenesis and required for efficient neurotransmission. After the initial contact of an axon with a target cell, Nrxn and Nlgn together recruit key synaptic components including neurotransmitter receptors and scaffolding proteins to promote synaptic assembly, maturation and differentiation (<xref ref-type="bibr" rid="B104">Krueger et al., 2012</xref>; <xref ref-type="bibr" rid="B153">Reissner et al., 2013</xref>; <xref ref-type="bibr" rid="B175">Sudhof, 2017</xref>). Overexpression of Nlgn or Nrxn can increase the number of synapses, leading to an alteration in the excitatory/inhibitory (E/I) ratio (<xref ref-type="bibr" rid="B35">Chih et al., 2004</xref>; <xref ref-type="bibr" rid="B38">Chubykin et al., 2007</xref>; <xref ref-type="bibr" rid="B47">Dahlhaus et al., 2010</xref>). E/I balance is necessary for appropriate circuit development and synaptic plasticity, and its alteration impairs information processing and social function, contributing to the pathogenesis of ASD and many other neurodevelopmental diseases (<xref ref-type="bibr" rid="B66">Gatto and Broadie, 2010</xref>; <xref ref-type="bibr" rid="B137">Nelson and Valakh, 2015</xref>). In <italic>Drosophila</italic>, Nlgn1 directly interacts with WAVE regulatory complex (WRC) and recruits WRC to postsynaptic sites to reorganize postsynaptic actin, thus maintaining normal synaptic formation and transmission in the <italic>Drosophila</italic> neuromuscular junction (NMJ) (<xref ref-type="bibr" rid="B214">Xing et al., 2018</xref>). Nlgn1 exerts its effect on differentiation and LTP of excitatory synapses via phosphorylation of intracellular tyrosine, which affects the recruitment of AMPARs (<xref ref-type="bibr" rid="B111">Letellier et al., 2018</xref>).</p>
<p>Nrxn- or Nlgn-deficient neurons display aberrant synaptic function, but not significant changes in the formation of synapses. Nrxn -1α deficient neurons show a selective reduction in the excitatory synaptic strength reflecting a decreased neurotransmitter release probability, leading to E/I imbalance (<xref ref-type="bibr" rid="B59">Etherton et al., 2009</xref>; <xref ref-type="bibr" rid="B141">Pak et al., 2015</xref>). Nrxn-1α acts as a positive regulator of Ca<sup>2+</sup> influx through α2δ-1 subunits that are responsible for trafficking and kinetic properties of Ca<sub>V</sub>2.1 pore-forming subunits, ensuring proper vesicle release (<xref ref-type="bibr" rid="B21">Brockhaus et al., 2018</xref>). Moreover, <italic>NRXN1</italic>-mutant human neurons exhibit increased levels of CASK, a scaffolding protein binding to Nrxn1, and mutations in <italic>CASK</italic> are associated with ASD, brain malformation, mental retardation (<xref ref-type="bibr" rid="B136">Najm et al., 2008</xref>; <xref ref-type="bibr" rid="B80">Hackett et al., 2010</xref>). Mice lacking Nrxn-2α display deficits in social behaviors and increased anxiety-like behaviors, accompanied by impaired glutamatergic release in the neocortex (<xref ref-type="bibr" rid="B45">Dachtler et al., 2014</xref>, <xref ref-type="bibr" rid="B46">2015</xref>; <xref ref-type="bibr" rid="B19">Born et al., 2015</xref>). Mice with combined deletion of Nrxn-2α and Nrxn2β show defects of excitatory release similar to mice lacking Nrxn-2α, indicating that Nrxn-2β has no strong function in basic transmission (<xref ref-type="bibr" rid="B19">Born et al., 2015</xref>). In addition, there is a significant decrease of Munc18-1 in the hippocampus of mice lacking Nrxn-2α, suggesting deficiencies in presynaptic vesicular release (<xref ref-type="bibr" rid="B45">Dachtler et al., 2014</xref>). Munc18-1 is involved in synaptic vesicle docking, priming and fusion (<xref ref-type="bibr" rid="B157">Rizo and Xu, 2015</xref>), encoded by <italic>STXBP1</italic>, which is also associated with ASD (<xref ref-type="bibr" rid="B205">Wang T. et al., 2016</xref>; <xref ref-type="bibr" rid="B194">Uddin et al., 2017</xref>). The cytoplasmic tail of Nrxn captures Munc18 via a multiprotein complex with involvement of Mint1 to facilitate presynaptic vesicular release (<xref ref-type="bibr" rid="B15">Biederer and Sudhof, 2000</xref>).</p>
<p>Triple knockout mice lacking Nlgn1-3 die shortly after birth due to severely impaired synaptic transmission of both excitatory and inhibitory synapses, but the density of synaptic contacts is not altered (<xref ref-type="bibr" rid="B198">Varoqueaux et al., 2006</xref>). Mice with Nlgn1 deletion show reduced NMDA/AMPR ratio in the striatum, accounting for a dramatic increase in repetitive, stereotyped grooming behavior, and the NMDAR partial co-agonist D-cycloserine can rescue this phenotype (<xref ref-type="bibr" rid="B17">Blundell et al., 2010</xref>). Mice with R451C substitution in Nlgn3 show an increased AMPAR- and NMDAR-mediated synaptic transmission and enhanced LTP in the hippocampus (possibly explaining the observed enhanced spatial learning abilities), but in the somatosensory cortex, inhibitory synaptic transmission is increased without apparent alteration in excitatory transmission (<xref ref-type="bibr" rid="B181">Tabuchi et al., 2007</xref>; <xref ref-type="bibr" rid="B60">Etherton et al., 2011a</xref>; <xref ref-type="bibr" rid="B93">Jaramillo et al., 2014</xref>). R451C substitution causes retention of Nlgn3 in the endoplasmic reticulum, resulting in decreasing delivery of Nlgn3 to the postsynaptic membranes (<xref ref-type="bibr" rid="B42">Comoletti et al., 2004</xref>). Strangely, mice with deletion of Nlgn3 do not exhibit any of these change (<xref ref-type="bibr" rid="B181">Tabuchi et al., 2007</xref>; <xref ref-type="bibr" rid="B61">Etherton et al., 2011b</xref>). It has been shown that knockout of <italic>Nlgn3</italic> late in development produces a marked synaptic phenotype, but no detectable effects are seen after knockout during early development, apparently due to developmental compensation by cerebellin-1 (Clbn1), a secreted protein binding to Nrxn (<xref ref-type="bibr" rid="B214">Xing et al., 2018</xref>). This may explain why <italic>Nlgn3</italic> KO mice have no phenotype in previous studies. R704C substitution in Nlgn3 results in a major and selective decrease in AMPAR-mediated synaptic transmission in pyramidal neurons of hippocampus, without altering NMDAR- and GABAR-mediated synaptic transmission, as well as presynaptic neurotransmitter release (<xref ref-type="bibr" rid="B61">Etherton et al., 2011b</xref>). <italic>Nlgn4</italic> KO significantly decreases the peak amplitude and the frequency of spontaneous inhibitory postsynaptic currents (sIPSCs), without changing mIPSCs, sEPSCs and mEPSCs in CA3 pyramidal cells, confirming that Nlgn4 knockout affects primarily inhibitory transmission (<xref ref-type="bibr" rid="B81">Hammer et al., 2015</xref>).</p>
</sec>
</sec>
<sec>
<title>Scaffolding Proteins</title>
<sec>
<title>2.1 PSD-95</title>
<p>PSD-95, encoded by the <italic>DLG4</italic> gene, is the central element of postsynaptic architecture of excitatory synapses. Rare missense mutations and CNVs in <italic>DLG4</italic> may increase susceptibility for ASD and SCZ (<xref ref-type="bibr" rid="B158">Roberts et al., 2014</xref>; <xref ref-type="bibr" rid="B204">Wang J. et al., 2016</xref>; <xref ref-type="bibr" rid="B215">Xing et al., 2016</xref>). Recently, truncation variants in <italic>DLG4</italic> have been reported to be responsible for ID with marfanoid features (<xref ref-type="bibr" rid="B133">Moutton et al., 2018</xref>). Through its three PDZ domains, an SH domain and a guanylate kinase homology (GK) domain, PSD-95 potentially binds to many key constituent PSD proteins, including AMPARs via Stargazin/TARP, NMDARs, adhesion molecules like Nlgn1, and other scaffolding proteins, such as GKAP. The binding diversity suggests that it is of critical importance for synaptic structural organization (<xref ref-type="bibr" rid="B62">Feng and Zhang, 2009</xref>). Overexpression of PSD-95 shifts the distribution of Nlgn2 from inhibitory synapses to excitatory synapses, resulting in a decrease in the total number of inhibitory synapses, demonstrating that levels of PSD-95 can manipulate the E/I balance (<xref ref-type="bibr" rid="B112">Levinson et al., 2005</xref>). RNAi knockdown of PSD-95 results in shortening and thinning of PSD and loss of putative AMPAR-type structures, confirming that PSD-95 is essential for sustaining molecular organization of PSD (<xref ref-type="bibr" rid="B34">Chen et al., 2011</xref>). Time-lapse imaging of axon-dendrite contacts shows that overexpression of PSD-95 reduces the turnover rates of pre- and postsynaptic structures, thus promoting the stabilization of putative synaptic contacts (<xref ref-type="bibr" rid="B182">Taft and Turrigiano, 2014</xref>).</p>
<p>PSD-95 exerts a strong influence on synaptic strength through its role in controlling neurotransmitter receptors. Complete genetic deletion of PSD-95 leads to the reduction in the number of AMPARs in synapses, forming silent synapses that contain a high abundance of NMDARs but no AMPARs. This bears important consequences for enhanced LTP, because during LTP expression, synaptic strength increases due to the incorporation of AMPARs into postsynaptic membranes (<xref ref-type="bibr" rid="B13">Béïque et al., 2006</xref>; <xref ref-type="bibr" rid="B88">Huang et al., 2015</xref>). In addition, PSD-95 downregulation increases the clustering of NR2B-containing NMDARs, which are characterized by slow kinetics and long decay time, resulting in a larger flow of Ca<sup>2+</sup> (<xref ref-type="bibr" rid="B13">Béïque et al., 2006</xref>; <xref ref-type="bibr" rid="B26">Bustos et al., 2014</xref>). NR2B subunit plays an essential role in the synaptic maturation and working memory functions, but its overabundance may lead to increased susceptibility to neuroexcitotoxicity (<xref ref-type="bibr" rid="B129">Monaco et al., 2015</xref>).</p>
</sec>
<sec>
<title>Gephyrin</title>
<p>Gephyrin, encoded by <italic>GPHN</italic> gene, is a key scaffolding protein at the inhibitory synapses, comprising three functional domains, G-, C- and E-domain. Rare de novo or inherited microdeletions and point mutations of <italic>GPHN</italic> have been reported in the patients with ASD, seizures and epileptic encephalopathy (<xref ref-type="bibr" rid="B116">Lionel et al., 2013</xref>; <xref ref-type="bibr" rid="B51">Dejanovic et al., 2014a</xref>, <xref ref-type="bibr" rid="B50">2015</xref>; <xref ref-type="bibr" rid="B87">Hu et al., 2015</xref>). Cohort studies with large sample size add to the growing evidence that CNVs involving <italic>GPHN</italic> contribute to ASD (<xref ref-type="bibr" rid="B150">Prasad et al., 2012</xref>; <xref ref-type="bibr" rid="B56">Egger et al., 2014</xref>). Gephyrin directly interacts with β-subunit of glycine receptors (GlyR) and α-subunits of GABA<sub>A</sub> receptor (GABA<sub>A</sub>R) via its E-domain. Nlgn2 preferentially binds to gephyrin through a conserved tyrosine residue to activate the gephyrin-interacting protein collybistin, a neuron-specific GDP/GTP exchange factor. Gephyrin thus acts as a molecular hub to promote the clustering of inhibitory neurotransmitter receptors and regulate the formation and extension of the inhibitory postsynaptic specialization.</p>
<p>Unlike their counterparts at glutamatergic synapses, gephyrin and its binding partners lack canonical protein interaction motifs, suggesting that they rely on different regulation mechanisms such as posttranslational modification. Gephyrin monomers oligomerize to form a hexagonal lattice of gephyrin clusters underneath the cell membrane that slow the lateral mobility of GlyRs and GABA<sub>A</sub>Rs, thus allowing their clustering at postsynaptic sites (<xref ref-type="bibr" rid="B78">Groeneweg et al., 2018</xref>). Phosphorylation of gephyrin on S270 by GSK-3β, on S268 by ERK and on S305 by CaMKII modulate the density and size of gephyrin clusters, thus affecting GABAergic transmission and homeostatic synaptic plasticity (<xref ref-type="bibr" rid="B193">Tyagarajan et al., 2011</xref>, <xref ref-type="bibr" rid="B192">2013</xref>; <xref ref-type="bibr" rid="B63">Flores et al., 2015</xref>). It has been shown that small ubiquitin-like modifier (SUMO)-ylation acts upstream of phosphorylation on S268 of gephyrin (<xref ref-type="bibr" rid="B71">Ghosh et al., 2016</xref>). Palmitoylation of gephyrin, found to be GABA<sub>A</sub>R activity-dependent, is crucial for the association of gephyrin with postsynaptic membranes and for gephyrin clustering, and also strengthens GABAergic synaptic transmission (<xref ref-type="bibr" rid="B53">Dejanovic et al., 2014b</xref>). Inhibition of nitric oxide synthase (nNOS) results in a loss of S-nitrosylation of gephyrin and the formation of larger gephyrin clusters, ultimately increasing the number of GABA<sub>A</sub>Rs on the postsynaptic membranes (<xref ref-type="bibr" rid="B52">Dejanovic and Schwarz, 2014</xref>). PKC-dependent phosphorylation and calcineurin-dependent dephosphorylation of growth-associated protein 43 (GAP-43), an activity-dependent phosphoprotein mediating neurite growth, are also related to gephyrin folding and clustering (<xref ref-type="bibr" rid="B203">Wang et al., 2015</xref>). Expression of chemically induced LTP of inhibition (iLTP) requires synaptic recruitment of gephyrin from extrasynaptic areas to immobilize and confine GABA<sub>A</sub>Rs at synapses, which in turn is promoted by CaMKII-dependent phosphorylation of GABA<sub>A</sub>R-β3-Ser383 (<xref ref-type="bibr" rid="B145">Petrini et al., 2014</xref>).</p>
</sec>
<sec>
<title>Shank</title>
<p>Shank (also known as ProSAP) proteins consist of three major isoforms, Shank1, Shank2, and Shank3, which have similar sets of domains: N-terminal ankyrin repeats, a Src homology 3 (SH3) domain, a PSD-95/Discs large/ZO-1 (PDZ) domain, a long proline-rich region, and a sterile alpha motif (SAM) domain. As master scaffolding proteins at the PSD of excitatory synapses, Shank proteins interact with more than 30 synaptic proteins through these multiple domains, essential for synaptic formation, glutamate receptor trafficking and neuronal signaling (<xref ref-type="bibr" rid="B130">Monteiro and Feng, 2017</xref>). In <italic>Drosophila</italic>, both deletion and overexpression of Shank result in defects in synaptic bouton number and maturation via regulating the internalization of the Wnt receptor Frizzled-2 (Fz2) (<xref ref-type="bibr" rid="B82">Harris et al., 2016</xref>).</p>
<p>Shank3 is encoded by <italic>SHANK3</italic>, located on chromosome 22q13.3. <italic>SHANK3</italic> was first identified in the 22q13.3 deletion syndrome, also known as Phelan-McDermid Syndrome (PMS), which is characterized by global developmental delay (<xref ref-type="bibr" rid="B148">Phelan et al., 2001</xref>; <xref ref-type="bibr" rid="B147">Phelan and McDermid, 2012</xref>). More than 50% of the patients with PMS show autism and autistic-like behaviors. <italic>SHANK3</italic> variants including de novo deletions, insertion, splicing mutations and point mutations have been identified in ASD patients (<xref ref-type="bibr" rid="B55">Durand et al., 2007</xref>; <xref ref-type="bibr" rid="B70">Gauthier et al., 2009</xref>; <xref ref-type="bibr" rid="B18">Boccuto et al., 2013</xref>). Prevalence of <italic>SHANK3</italic> variants in patients with ASD and ID is estimated to 1–2%, whereas <italic>SHANK1</italic> and <italic>SHANK2</italic> mutations are much rarer (<xref ref-type="bibr" rid="B18">Boccuto et al., 2013</xref>; <xref ref-type="bibr" rid="B108">Leblond et al., 2014</xref>). Shank3-deficient neurons show reduced levels of PSD proteins including GKAP, Homer1b/c, AMPAR subunit GluA1 and NMDAR subunit NR2A (<xref ref-type="bibr" rid="B144">Peca et al., 2011</xref>; <xref ref-type="bibr" rid="B206">Wang et al., 2011</xref>). Disrupted interactions among Shank3, GKAP and Homer1b/c may account for the impaired activity-dependent redistribution of the GluA1 subunit, leading to reduced post-tetanic potentiation and hippocampal LTP (<xref ref-type="bibr" rid="B206">Wang et al., 2011</xref>). Neurons induced from pluripotent stem cells (iPSCs) in patients with PMS show significantly impaired NMDAR- and AMPAR-mediated synaptic transmission (<xref ref-type="bibr" rid="B166">Shcheglovitov et al., 2013</xref>). Shank3 deficient mice display self-injurious repetitive grooming and deficits in social interaction with significant reductions in frequency and peak amplitude of mEPSCs, which suggests a decreased number of functional synapses and reduced postsynaptic response from the available synapses, respectively (<xref ref-type="bibr" rid="B144">Peca et al., 2011</xref>). In contrast, overexpression of Shank3 leads to a dramatic increase in the amplitude of evoked AMPAR- and NMDAR-mediated EPSCs, as well as higher frequency of AMPAR-mediated mEPSCs (<xref ref-type="bibr" rid="B3">Arons et al., 2012</xref>).</p>
<p>Shank2 is encoded by <italic>SHANK2</italic>, located on chromosome 11q13.3-q13.4. <italic>SHANK2</italic> variations including deletions, missense mutations, truncations, and mutations in the <italic>SHANK2</italic> promoter regions have been identified, linking <italic>SHANK2</italic> variants to ASD and ID (<xref ref-type="bibr" rid="B14">Berkel et al., 2010</xref>). Single nucleotide polymorphisms (SNPs) in <italic>SHANK2</italic> introns are also implicated in ASD risk (<xref ref-type="bibr" rid="B6">Bai et al., 2018</xref>). Discrepant effects on synaptic transmission and long-term plasticity are reported in two independently generated <italic>Shank2</italic> KO mice, <italic>Shank2</italic> Δ<italic>e7<sup>–/–</sup></italic> and <italic>Shank2 e6-7<sup>–/–</sup></italic>. <italic>Shank2</italic> Δ<italic>e7<sup>–/–</sup></italic> mice (<xref ref-type="bibr" rid="B164">Schmeisser et al., 2012</xref>) display extreme hyperactivity and profound autism-like behavior, such as repetitive grooming and abnormalities in vocal and social behaviors, accompanied by reduced basal synaptic transmission, decreased frequency of mEPSCs and an increased NMDA/AMPA ratio consistent with increased levels of the NMDAR subunit GluN1 in the hippocampus and striatum. LTP of Schaffer collaterals is slightly enhanced in <italic>Shank2</italic> Δ<italic>e7<sup>–/–</sup></italic> mice, but no evidence for alterations in LTD. Recently, <xref ref-type="bibr" rid="B207">Wegener et al. (2018)</xref> reproduced these results in <italic>Shank2</italic> Δ<italic>e7<sup>–/–</sup></italic> mice and further uncovered a developmental synapse phenotype, an excess of silent synapses, which explains the phenomena of decreased synaptic transmission and enhanced LTP. <italic>Shank2</italic> Δ<italic>e6-7<sup>–/–</sup></italic> mice (<xref ref-type="bibr" rid="B213">Won et al., 2012</xref>) exhibit hyperactivity and autism-like behavior too, though with a reduced NMDA/AMPA ratio and selectively decreased NMDAR-mediated synaptic transmission, as well as severely impaired LTP and LTD. Direct stimulation of NMDARs with D-cycloserine (a partial agonist of NMDARs), and a positive allosteric modulator of metabotropic glutamate receptor 5 (mGluR5) that enhances NMDAR function via mGluR5 activation can normalize NMDAR function and improves social interaction of <italic>Shank2</italic> Δ<italic>e6-7<sup>–/–</sup></italic> mice. Mice with conditional <italic>Shank2</italic> deletion (exon 6–7) restricted to parvalbumin (PV)-positive neurons display moderate hyperactivity and enhanced self-grooming, suggesting that <italic>Shank2</italic> deletion in PV-positive neurons contributes to the hyperactivity observed in global <italic>Shank2</italic>-KO mice (<xref ref-type="bibr" rid="B109">Lee et al., 2018</xref>). Interestingly, expression levels of <italic>Gabra2</italic> and GABA<sub>A</sub>R-mediated inhibitory synaptic transmission are reduced in <italic>Shank2</italic> Δ<italic>e6-7<sup>–/–</sup></italic> mice, but not in <italic>Shank2</italic> Δ<italic>e7<sup>–/–</sup></italic> mice, and enhancing inhibitory synaptic function with an allosteric modulator for the GABAA Rs reverses spatial memory deficits in <italic>Shank2</italic> Δ<italic>e6-7<sup>–/–</sup></italic> mice (<xref ref-type="bibr" rid="B115">Lim et al., 2017</xref>).</p>
<p>Shank1 is encoded by <italic>SHANK1</italic>, located on chromosome 19q13.33. Deletions and point mutations of <italic>SHANK1</italic> have been identified in ASD individuals, indicating the involvement of <italic>SHANK1</italic> in ASD (<xref ref-type="bibr" rid="B163">Sato et al., 2012</xref>). Mice completely lacking all Shank1 protein isoforms (<italic>Shank1<sup>–/–</sup></italic> mice) have increased anxiety-related behavior, impaired contextual fear memory and object recognition memory (<xref ref-type="bibr" rid="B91">Hung et al., 2008</xref>; <xref ref-type="bibr" rid="B178">Sungur et al., 2017</xref>), as well as social communication/interaction deficits (<xref ref-type="bibr" rid="B212">Wohr et al., 2011</xref>; <xref ref-type="bibr" rid="B179">Sungur et al., 2016</xref>). Adult, but not juvenile <italic>Shank<sup>+/-</sup></italic> heterozygous and <italic>Shank1<sup>–/–</sup></italic> null mutant mice displayed slightly elevated levels of self-grooming behavior (<xref ref-type="bibr" rid="B180">Sungur et al., 2014</xref>). <xref ref-type="bibr" rid="B167">Silverman et al. (2011)</xref> found that motor functions were reduced on open field activity, rotarod, and wire hang in <italic>Shank1<sup>–/–</sup></italic> mutants, extending the role of Shank1 to motor functions. <italic>Shank1<sup>–/–</sup></italic> mice show smaller dendritic spines, thinner and smaller PSD, and altered PSD protein composition, as well as weaker basal synaptic transmission, affirming the importance of Shank1 for synaptic structure and function <italic>in vivo</italic> (<xref ref-type="bibr" rid="B91">Hung et al., 2008</xref>). Shank1 is highly expressed in parvalbumin-expressing (PV+) fast-spiking inhibitory interneurons in hippocampus, and loss of Shank1 causes increased E/I ratio by weakening inhibitory synaptic function, which is consistent with decreased expression of gephyrin (<xref ref-type="bibr" rid="B122">Mao et al., 2015</xref>).</p>
</sec>
</sec>
<sec>
<title>Synaptic Gene Transcription, Protein Synthesis and Degradation</title>
<p>It is well accepted that a stable proteome is important for synaptic plasticity, and dysregulation of synaptic protein synthesis, recycling, and degradation at the activated synapse is implicated in the pathogenesis of neurological diseases including ASD, ID and epilepsy (<xref ref-type="bibr" rid="B29">Cajigas et al., 2010</xref>; <xref ref-type="bibr" rid="B102">Klein et al., 2016</xref>; <xref ref-type="bibr" rid="B118">Louros and Osterweil, 2016</xref>). Of special interest is the phosphoinositide 3-kinase /AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway, which acts as a central regulator of a diverse array of cellular processes, including cell growth, proliferation and protein translation. Components of the mTOR pathway are present at synapses, where they play important roles in synaptogenesis, synaptic transmission and plasticity.</p>
<sec>
<title>TSC1/2</title>
<p>Hamartin (TSC1) and tuberin (TSC2) are protein products of the <italic>TSC1</italic> and <italic>TSC2</italic> genes, respectively. These two proteins together with the recently identified protein TBC1D7 form a complex that inhibits the activity of mTOR complex 1 (mTORC1) through the inhibition of Ras homolog expressed in brain (Rheb), a GTPase located upstream of mTORC1. Spontaneous or inherited mutations in <italic>TSC1</italic> and <italic>TSC2</italic> genes lead to dysfunction of the TSC1/TSC2/TBC1D7 complex and disinhibition of mTORC1, thus resulting in tuberous sclerosis complex (TSC). TSC is a neurocutaneous disorder characterized by the formation of hamartomas in multiple organs, and neurological manifestations including epilepsy, ID and ASD. ASD is estimated to affect about 40% of patients with TSC (<xref ref-type="bibr" rid="B154">Richards et al., 2015</xref>), and epilepsy is one of the risk factors for the development of ASD in TSC patients (<xref ref-type="bibr" rid="B200">Vignoli et al., 2015</xref>; <xref ref-type="bibr" rid="B128">Mitchell et al., 2017</xref>).</p>
<p>Both heterozygous and homozygous loss of <italic>Tsc1</italic> in mouse cerebellar Purkinje cells (PCs) result in autistic-like behaviors, including abnormal social interaction, repetitive behavior, and vocalizations (<xref ref-type="bibr" rid="B190">Tsai P.T. et al., 2012</xref>). PCs in the model mouse show significantly reduced spontaneous EPSC (sEPSC) frequency and mEPSC frequency, indicating a decreased number of functional glutamatergic synapses; importantly, human neurons derived from TSC2-deficient iPSCs display the same defects (<xref ref-type="bibr" rid="B43">Costa et al., 2016</xref>; <xref ref-type="bibr" rid="B177">Sundberg et al., 2018</xref>). The expression levels of the PC-specific glutamate receptor δ2 (GRID2), the postsynaptic marker PSD-95, and presynaptic marker synaptophysin (SYP1) are all reduced, suggesting abnormal synaptic development (<xref ref-type="bibr" rid="B177">Sundberg et al., 2018</xref>). High-throughput RNA sequencing reveals a down-regulation of genes associated with neurogenesis and glutamate receptor signaling in cortical tubers of TSC patients (<xref ref-type="bibr" rid="B127">Mills et al., 2017</xref>).</p>
<p>Eker rats, which carry a spontaneous <italic>Tsc2</italic> germline mutation, exhibit marked reduction in LTP and LTD elicited by different protocols in hippocampal synapses (<xref ref-type="bibr" rid="B201">von der Brelie et al., 2006</xref>). Mice with a heterozygous mutation of <italic>Tsc2</italic> show a reduced threshold for late-phase of LTP in the CA1 region of hippocampus, which can lead to inappropriate storage of unrelated or unprocessed information, thus impairing hippocampal-dependent learning (<xref ref-type="bibr" rid="B57">Ehninger et al., 2008</xref>). Mutations in both <italic>TSC1</italic> and <italic>TSC2</italic> abolish metabotropic glutamate receptor-dependent LTD (mGluR-LTD) in hippocampal CA1 synapses, without affecting NMDAR-mediating LTD (<xref ref-type="bibr" rid="B5">Auerbach et al., 2011</xref>; <xref ref-type="bibr" rid="B12">Bateup et al., 2011</xref>). Inhibition by negative allosteric modulator (NAM) of mGluR5 corrects hyperactivity, seizures and elevated synaptic protein synthesis in <italic>Tsc2</italic> mutant mice, whereas positive allosteric modulation of mGluR5 results in the exacerbation of hyperactivity and epileptic phenotypes, suggesting a meaningful therapeutic potential for mGluR5 NAM in TSC (<xref ref-type="bibr" rid="B100">Kelly et al., 2018</xref>).</p>
</sec>
<sec>
<title>PTEN</title>
<p>PTEN (phosphatase and tensin homolog), encoded by the <italic>PTEN</italic> gene on chromosome 10q23, is a dual lipid/protein phosphatase, best known for its role in tumor suppression. PTEN dephosphorylates phosphatidylinositol 3,4,5-trisphosphate (PIP3) to generate the bisphosphate product phosphatidylinositol 4,5-bisphosphate (PIP2), further negatively regulating the PI3K/AKT/mTOR signaling pathway, ultimately inhibiting cellular survival and proliferation. PTEN is also highly expressed in the central nervous system, where it is intimately involved in neuronal growth and synaptic function. Loss-of-function mutations in <italic>PTEN</italic> contribute to macrocephaly, seizures, ASD and mental retardation (<xref ref-type="bibr" rid="B27">Butler et al., 2005</xref>; <xref ref-type="bibr" rid="B28">Buxbaum et al., 2007</xref>; <xref ref-type="bibr" rid="B139">Orrico et al., 2009</xref>; <xref ref-type="bibr" rid="B197">Varga et al., 2009</xref>), and incomplete loss of <italic>PTEN</italic> function is more commonly linked to ASD (<xref ref-type="bibr" rid="B171">Spinelli et al., 2015</xref>). <italic>PTEN</italic> mutations are found in 7–27% of macrocephalic ASD individuals and 8% of macrocephalic ID patients (<xref ref-type="bibr" rid="B124">McBride et al., 2010</xref>; <xref ref-type="bibr" rid="B84">Hobert et al., 2014</xref>).</p>
<p>Conditional knockout (cKO) mice in which Pten is ablated in granule cells of dentate gyrus (DGC) were reported to show increased evoked synaptic transmission in both glutamatergic and GABAergic neurons, resulting from an increase in the number of synaptic vesicles available for release and upregulated synaptogenesis (<xref ref-type="bibr" rid="B209">Weston et al., 2012</xref>). However, others studying Pten-deleted neurons reported increased excitatory synaptic currents but unchanged IPSC amplitude, thus shifting the E/I balance, leading to hyperactivity of mutant neurons (<xref ref-type="bibr" rid="B119">Luikart et al., 2011</xref>; <xref ref-type="bibr" rid="B211">Williams et al., 2015</xref>). cKO of <italic>Pten</italic> in PCs results in autistic-like traits in adult <italic>Pten</italic>-mutant mice, and mutant PCs show structural abnormalities in dendrites and axons and decreased excitability, as well as altered excitatory postsynaptic currents (<xref ref-type="bibr" rid="B44">Cupolillo et al., 2016</xref>). Although loss of <italic>PTEN</italic> during early development is associated with substantial structural abnormalities, it has been shown that the effects of <italic>PTEN</italic> on neuronal morphology and synaptic function are independent of each other. cKO mice with Pten deletion restricted to forebrain excitatory neurons displayed impaired LTP and LTD at excitatory hippocampal synapses without any changes in morphology, which coincides with impaired spatial memory (<xref ref-type="bibr" rid="B170">Sperow et al., 2012</xref>). Pten-deleted DGC synapses showed enhanced theta burst-induced LTP and impaired mGluR-LTD prior to the onset of gross morphological defects (<xref ref-type="bibr" rid="B183">Takeuchi et al., 2013</xref>). PTEN can modulate synaptic activity via a PDZ-dependent association between PTEN and PSD-95 triggered by NMDAR activation, the PTEN then becomes anchored to the postsynaptic membranes, driving depression of the AMPA receptor-mediated synaptic responses required for NMDAR-LTD (<xref ref-type="bibr" rid="B96">Jurado et al., 2010</xref>).</p>
</sec>
<sec>
<title>FMRP</title>
<p>Fragile mental retardation protein (FMRP), encoded by <italic>FMR1</italic>, functions as an mRNA-binding translational suppressor, and is also involved in RNA-, channel- and protein binding to modulate synaptic transmission and plasticity (<xref ref-type="bibr" rid="B49">Davis and Broadie, 2017</xref>). Fragile X syndrome (FXS), the most common form of inherited ID and the most common monogenic cause of ASD, is caused by the loss of FMRP. 60–74% of male and 16–45% of female FXS patients meet the diagnostic criteria of ASD (<xref ref-type="bibr" rid="B103">Klusek et al., 2014</xref>). Nearly 1,000 high-confidence FMRP-associated transcripts have been identified (<xref ref-type="bibr" rid="B48">Darnell et al., 2011</xref>; <xref ref-type="bibr" rid="B184">Tang et al., 2015</xref>), and there is substantial overlap between putative FMRP target mRNAs and ASD-related mRNAs (<xref ref-type="bibr" rid="B134">Muddashetty et al., 2011</xref>; <xref ref-type="bibr" rid="B220">Zhang et al., 2014</xref>). Therefore, the commonly observed ASD endophenotype of FXS might reflect a “multiple hit” effect on the expression of ASD-related genes caused by loss of FMRP.</p>
<p>FMRP plays a key role in the dynamic regulation of the synaptic proteome. FMRP associates with <italic>Nlgn1</italic>, <italic>Nlgn2</italic> and <italic>Nlgn3</italic> mRNAs; consequently, <italic>Fmr1</italic> KO leads to elevated local translation of <italic>Nlgn</italic> mRNAs and increased targeting of Nlgn1 and Nlgn3 to postsynaptic membranes (<xref ref-type="bibr" rid="B37">Chmielewska et al., 2018</xref>). FMRP binds to a G-rich region of PSD-95 mRNA, and together with microRNA miR-125a, plays an important role in the reversible inhibition of PSD-95 mRNA translation in neurons (<xref ref-type="bibr" rid="B134">Muddashetty et al., 2011</xref>; <xref ref-type="bibr" rid="B172">Stefanovic et al., 2015</xref>). However, recently, it was revealed that FMRP enhances rather than represses the translation of large ASD-related proteins; this discrepancy may arise because many FMRP targets act negatively on translation, protein stability or cell growth (<xref ref-type="bibr" rid="B76">Greenblatt and Spradling, 2018</xref>).</p>
<p>In <italic>Fmr1</italic> KO mice, mGluR-LTD in the CA1 region of hippocampus is exaggerated (<xref ref-type="bibr" rid="B86">Hou et al., 2006</xref>; <xref ref-type="bibr" rid="B186">Till et al., 2015</xref>), while mGluR5 is less associated with the long Homer isoforms and more associated with short Homer 1a (<xref ref-type="bibr" rid="B74">Giuffrida et al., 2005</xref>; <xref ref-type="bibr" rid="B159">Ronesi et al., 2012</xref>). The long Homer proteins, Homer 1b, 1c, 2 and 3, target mGluR5 to the PSD though their interaction with Shank proteins, whereas the short Homer 1a uncouples mGlu5R from postsynaptic membranes (<xref ref-type="bibr" rid="B97">Kammermeier and Worley, 2007</xref>). Therefore, mGluR5 is significantly more mobile at hippocampal synapses of <italic>FMR1</italic> KO mice, causing increased co-clustering of mGluR5 and NMDAR, which correlates with reduced amplitude of NMDAR currents and the absence of NMDAR-LTD (<xref ref-type="bibr" rid="B2">Aloisi et al., 2017</xref>). The enhanced mGluR-LTD is likely caused by dysregulated NMDAR signaling. Blocking GluN2B rescued mGluR-LTD, suggesting that GluN2B-containing NMDARs are hyperactive in <italic>Fmr1</italic> KO mice (<xref ref-type="bibr" rid="B187">Toft et al., 2016</xref>). Moreover, NMDAR-LTP is decreased in the hippocampus of <italic>Fmr1</italic> KO rats and mice, and pharmacological or genetic blockage of GluN2A-containing NMDARs completely rescues LTP and mGluR-LTD (<xref ref-type="bibr" rid="B185">Tian et al., 2017</xref>; <xref ref-type="bibr" rid="B120">Lundbye et al., 2018</xref>). In addition to the mGluR hyperexcitability theory, GABAergic hypoinhibition that leads to E/I imbalance may cause disease symptoms. In mouse and <italic>Drosophila</italic> FXS models, the mRNA and protein levels of GABA<sub>A</sub>R and glutamic acid decarboxylase (GAD), the rate-limiting GABA synthesis enzyme, are downregulated (<xref ref-type="bibr" rid="B1">Adusei et al., 2010</xref>; <xref ref-type="bibr" rid="B67">Gatto et al., 2014</xref>). In the cerebellum of <italic>Fmr1</italic> KO mice, excessive GABA release from basket cell synapses, which results from increased excitability and Ca<sup>2+</sup> transients in the presynaptic sites due to disruption of the interaction between FMRP and K<sub>V</sub>1.2, suppresses the firing activity of Purkinje neurons (<xref ref-type="bibr" rid="B217">Yang et al., 2018</xref>).</p>
</sec>
<sec>
<title>UBE3A</title>
<p>Ubiquitin-protein ligase E3A (UBE3A) is encoded by <italic>UBE3A</italic> gene, located in an imprinted region on chromosome 15q11-q13. Loss of function of the maternally expressed <italic>UBE3A</italic> gene gives rise to Angelman Syndrome (AS), characterized by microcephaly, ID, motor abnormalities, profound speech impairment, epilepsy and a unique behavioral pattern, including a happy demeanor (<xref ref-type="bibr" rid="B25">Buiting et al., 2016</xref>). The duplication or triplication of maternally inherited 15q11-q13 is associated with ASD, accounting for 1–3% of ASD cases worldwide (<xref ref-type="bibr" rid="B85">Hogart et al., 2010</xref>; <xref ref-type="bibr" rid="B106">LaSalle et al., 2015</xref>). UBE3A transfers ubiquitin from an E2 ubiquitin-conjugating enzyme to the substrate proteins, thus tagging these substrate proteins for proteasomal degradation. Not surprisingly, function deficits of UBE3A can increase the synaptic abundance of its substrate proteins and dysregulate many synaptic processes including synapse development, elimination, and function.</p>
<p><italic>Drosophila</italic> with <italic>dUbe3a</italic> mutations have excess synaptic boutons and endocytic defects at neuromuscular junction terminals due to enhanced level of bone morphogenetic protein (BMP) signaling, crucial to neurodevelopment throughout evolution (<xref ref-type="bibr" rid="B114">Li et al., 2016b</xref>). In <italic>Ube3a<sup>m-/p+</sup></italic> neurons, Arc protein accumulates due to a lack of degradation, leading to the excessive internalization of AMPARs, eventually disrupting homeostatic synaptic scaling of AMPARs (<xref ref-type="bibr" rid="B77">Greer et al., 2010</xref>; <xref ref-type="bibr" rid="B105">Kuhnle et al., 2013</xref>; <xref ref-type="bibr" rid="B143">Pastuzyn and Shepherd, 2017</xref>). <italic>Ube3a<sup>m-/p+</sup></italic> mice show strongly decreased inhibitory transmission and increased excitatory transmission, leading to marked E/I imbalance. This is accompanied by an abnormal accumulation of clathrin-coated vesicles at inhibitory axon terminals, suggesting a defect in vesicle cycling (<xref ref-type="bibr" rid="B202">Wallace et al., 2012</xref>; <xref ref-type="bibr" rid="B95">Judson et al., 2016</xref>; <xref ref-type="bibr" rid="B160">Rotaru et al., 2018</xref>). In contrast, increasing gene dosage of <italic>Ube3a</italic> suppresses glutamatergic, but not GABAergic, synaptic transmission as a result of reduced presynaptic release probability, synaptic glutamate concentration, and postsynaptic action potential coupling (<xref ref-type="bibr" rid="B168">Smith et al., 2011</xref>). Besides, excessive UBE3A dosage is found to impair retinoic acid-mediated neuronal homeostatic synaptic plasticity (<xref ref-type="bibr" rid="B216">Xu et al., 2018</xref>). <italic>UBE3A<sup>m-/p+</sup></italic> mice show severely impaired hippocampal LTP despite normal neuroanatomy and basal synaptic transmission, which may be the result of increased inhibitory phosphorylation of CaMKII and enhanced neuregulin-ErbB4 signaling, so both mutations that prevent inhibitory phosphorylation of αCaMKII and ErbB inhibitors can reverse these deficits in LTP (<xref ref-type="bibr" rid="B94">Jiang et al., 1998</xref>; <xref ref-type="bibr" rid="B196">van Woerden et al., 2007</xref>; <xref ref-type="bibr" rid="B99">Kaphzan et al., 2012</xref>). In UBE3A-deficient mice, the level of postsynaptic SK2, a member of the family of small-conductance calcium-activated potassium channels (SKs), is elevated, resulting in decreased NMDAR activation, thereby impairing hippocampal LTP (<xref ref-type="bibr" rid="B176">Sun et al., 2015</xref>). mGlu5 receptor-dependent LTD is enhanced in hippocampal slices of <italic>Ube3a <sup>m-/p+</sup></italic> mice. However, totally unlike the coupling changes observed in FXS mice, <italic>Ube3a <sup>m-/p+</sup></italic> mice show a reduced expression of Homer 1a and an increased coupling of mGluR5 and Homer 1/c (<xref ref-type="bibr" rid="B149">Pignatelli et al., 2014</xref>).</p>
</sec>
<sec>
<title>MeCP2</title>
<p>Methyl-CpG binding protein 2 (MeCP2), encoded by <italic>MECP2</italic> gene, is a nuclear protein that preferentially binds to methylated DNA over unmethylated DNA, leading to global transcriptional repression by recruiting corepressors, such as histone deacetylases and transcriptional silencing factors. Loss-of-function mutations in <italic>MECP2</italic> are the major cause of Rett Syndrome (RTT), an X-linked progressive neurodevelopmental disorder that nearly exclusively affects female patients. RTT patients experience an apparently normal postnatal development up to 6–18 months of age, and then neurological symptoms appear, including ID, autistic features, epilepsy and deteriorated motor and sensory function. Gain-of-function mutations in <italic>MECP2</italic> are associated with the neurodevelopmental disorder <italic>MECP2</italic> duplication syndrome, marked by severe ID, stunted motor development and epilepsy, as well as autistic-like features and anxiety.</p>
<p>MeCP2 can regulate synapse development and synaptic function, which is crucial for normal E/I balance. Hippocampal glutamatergic neurons that lack MeCP2 display reduced synaptic responses, whereas neurons with doubling of MeCP2 exhibit an enhancement in synaptic responses, primarily due to the alteration in the number of synapses formed (<xref ref-type="bibr" rid="B33">Chao et al., 2007</xref>). Wild-type GABAergic neurons in cerebral cortex express ∼50% more MeCP2 than non-GABAergic neurons, indicating Mecp2 might be particularly important to GABAergic function (<xref ref-type="bibr" rid="B32">Chao et al., 2010</xref>). MeCP2-deficient GABAergic neurons show reduced inhibitory quantal size, consistent with a presynaptic reduction of glutamic acid decarboxylase-1 (GAD-1) and GAD-2 levels (<xref ref-type="bibr" rid="B32">Chao et al., 2010</xref>). The expression levels of GABA transporter 1 (GAT1) and vesicular GABA transporter (vGAT) are significantly lower in the frontal cortex of <italic>Mecp2</italic> KO mice, implying a dysfunctional GABA recycling system (<xref ref-type="bibr" rid="B11">Barth et al., 2014</xref>). Loss of MeCP2 also accelerates the NMDAR subunit switch from Glu2B to 2A at excitatory synapses onto cortical PV cells, indicating an acceleration of NMDAR development, but delays this switch in pyramidal cells, suggesting a developmental delay (<xref ref-type="bibr" rid="B126">Mierau et al., 2016</xref>). The frequency and amplitude of mIPSCs is decreased, while the amplitude of mEPSCs is significantly enhanced in hippocampal pyramidal neurons of <italic>Mecp2</italic> KO male mice (<italic>Mecp2<sup>-/y</sup></italic>) and Mecp2 A140V mutant mice (<xref ref-type="bibr" rid="B121">Ma et al., 2014</xref>; <xref ref-type="bibr" rid="B30">Calfa et al., 2015</xref>). Naïve excitatory synapses in CA1 pyramidal neurons of <italic>Mecp2</italic> KO mice show larger AMPAR-mediated synaptic currents that results from a higher expression of GluA1-containing receptors (<xref ref-type="bibr" rid="B113">Li et al., 2016a</xref>). In the somatosensory cortex of <italic>Mecp2</italic>-null mice, AMPAR- and NMDAR-excitation is not altered, while postsynaptic inhibition is enhanced, as demonstrated by an increase in the amplitude of GABA<sub>A</sub>R-mediated sIPSCs and mIPSCs (<xref ref-type="bibr" rid="B117">Lo et al., 2016</xref>).</p>
<p>LTP and LTD are both attenuated in the hippocampus of <italic>Mecp2</italic> KO mice (<xref ref-type="bibr" rid="B4">Asaka et al., 2006</xref>). The similar impairments are also observed in mice with truncated mutation of <italic>Mecp2</italic> (<italic>Mecp2<sup>308</sup></italic>) and heterozygous female <italic>Mecp2-stop</italic> mice (<italic>Mecp2<sup>stop/-</sup></italic>) (<xref ref-type="bibr" rid="B131">Moretti et al., 2006</xref>; <xref ref-type="bibr" rid="B208">Weng et al., 2011</xref>). However, the underlying causes of this impaired LTP and LTD have not yet been thoroughly elucidated. One plausible mechanism for impaired LTP in <italic>Mecp2</italic>-null mice is the lack of activity-dependent trafficking of GluA1, since long-term plasticity is critically determined by activity-dependent insertion and removal of AMPARs to and from postsynaptic membranes (<xref ref-type="bibr" rid="B113">Li et al., 2016a</xref>). Moreover, an excess of free regulatory protein kinase A (PKA) subunits is seen in <italic>Mecp2<sup>-/y</sup></italic>, binding to cAMP and buffering cAMP levels to restrict its availability for PKA activation, perhaps explaining the observed defective LTP in <italic>Mecp2<sup>-/y</sup></italic> CA1 neurons (<xref ref-type="bibr" rid="B9">Balakrishnan et al., 2016</xref>). Mice with MeCP2 overexpression restricted in neurons (<italic>Tau-Mecp2</italic>) also display impaired hippocampal LTP (<xref ref-type="bibr" rid="B135">Na et al., 2012</xref>). With regard to short-term plasticity, loss-of-<italic>Mecp2</italic> function leads to reduced paired-pulse ratios (<xref ref-type="bibr" rid="B4">Asaka et al., 2006</xref>; <xref ref-type="bibr" rid="B131">Moretti et al., 2006</xref>; <xref ref-type="bibr" rid="B208">Weng et al., 2011</xref>), whereas gain-of-<italic>Mecp2</italic> function augments paired-pulse responses (<xref ref-type="bibr" rid="B40">Collins et al., 2004</xref>; <xref ref-type="bibr" rid="B135">Na et al., 2012</xref>).</p>
</sec>
</sec>
<sec>
<title>Synaptic Elimination</title>
<p>Besides abnormalities in synaptogenesis, synaptic neurotrans mission, and synaptic plasticity caused by mutations in ASD-linked genes, several ASD risk genes including <italic>MEF2C</italic>, <italic>FMR1</italic>, <italic>DLG4</italic>, and <italic>PCDH10</italic> are also involved in the process of synaptic elimination, so it is appropriate to discuss them as a whole (<xref ref-type="bibr" rid="B151">Ram Venkataraman et al., 2017</xref>), bearing in mind that completely different genetic causes can lead to a common cellular pathway leading to synaptic defects.</p>
<p>Maintenance of cognition and normal behaviors is heavily dependent on precise formation of mature neuronal circuits. During postnatal brain development, synaptic formation predominates at first, resulting in synapses in excess of functional need. Then in the subsequent postnatal period, activity-dependent elimination of redundant synapses decreases the number of synapses. In general, synaptic activity and the resulting neuronal depolarization and Ca<sup>2+</sup> influx activates the myocyte enhancer factor-2 (MEF2) family of transcription factors, inducing a rapid and robust synapse elimination (<xref ref-type="bibr" rid="B210">Wilkerson et al., 2014</xref>). <italic>MEF2C</italic> haploinsufficiency has been identified in patients who exhibit signs and syndromes that include ASD, ID and variable epilepsy (<xref ref-type="bibr" rid="B138">Novara et al., 2010</xref>; <xref ref-type="bibr" rid="B140">Paciorkowski et al., 2013</xref>). MEF2C acts as a convergent point in multiple regulatory pathways involved in the pathogenesis of ASD and ID (<xref ref-type="bibr" rid="B142">Parikshak et al., 2013</xref>; <xref ref-type="bibr" rid="B73">Gilissen et al., 2014</xref>).</p>
<p>MEF2-induced synapse elimination requires multiple autism-associated components. Deletion of MEF2C in mice causes a marked increase in the number of excitatory synapses, whereas neuronal expression of super-activating form of MEF2C leads to the reduced number of excitatory postsynaptic sites (<xref ref-type="bibr" rid="B10">Barbosa et al., 2008</xref>; <xref ref-type="bibr" rid="B146">Pfeiffer et al., 2010</xref>; <xref ref-type="bibr" rid="B39">Cole et al., 2012</xref>). However, MEF2 fails to eliminate functional or structural excitatory synapses in the hippocampus of <italic>Fmr1</italic> KO mice, demonstrating FMRP functions downstream of MEF2-induced synapse elimination, consistent with the excess dendritic spines seen in <italic>Fmr1</italic> KO mice and patients with FXS (<xref ref-type="bibr" rid="B146">Pfeiffer et al., 2010</xref>) FMRP and MEF2 cooperatively regulate the expression of protocadherin-10 (Pcdh10), a member of the cadherin superfamily of calcium-dependent cell adhesion molecules encoded by the <italic>PCDH10</italic> gene. MEF2 activation leads to PSD-95 ubiquitination by the ubiquitin E3 ligase Murine Double Minute-2 (Mdm2), which is then delivered by Pcdh10 to the proteasome for degradation (<xref ref-type="bibr" rid="B189">Tsai N. et al., 2012</xref>). Exonic CNVs in <italic>PTEN</italic> gene are associated with ASD (<xref ref-type="bibr" rid="B132">Morrow et al., 2008</xref>; <xref ref-type="bibr" rid="B23">Bucan et al., 2009</xref>). Mice lacking one copy of <italic>Pcdh10 (Pcdh10<sup>+/-</sup>)</italic> display reduced social approach behavior, as well as abnormal spine morphology, reduced levels of NMDAR subunits, and impaired gamma synchronization (<xref ref-type="bibr" rid="B165">Schoch et al., 2017</xref>). In neurons of <italic>Fmr1</italic> KO mice, elevating levels of eukaryotic translation elongation factor 1-alpha (EF1α), an FMRP target mRNA, prevents phosphatase 2A (PP2A) interaction with and dephosphorylation of Mdm2 upon MEF2 activation, rendering Mdm2 hyperphosphorylated and trapped in the nucleus (<xref ref-type="bibr" rid="B188">Tsai N. et al., 2017</xref>).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Although the etiology of ASD is highly heterogeneous, numerous studies have shed light on common cellular pathways that converge at synapses. The functions of proteins encoded by ASD risk genes are so complex that in most cases, a single protein is implicated in multiple synaptic aspects, including synapse formation and elimination, synaptic transmission and plasticity. The data reviewed above suggests that the pathogenesis of ASD, at least in part, can be attributed to synaptic dysfunction. The ASD phenotype can be seen as the ultimate result of multiple hits of genetic and environmental factors. Further elucidation of the underlying synaptopathology, and advances in gene therapies and targeted drugs to modulate these processes, could lead to promising new therapies for the treatment of ASDs.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>SG played a primary role in literature review and writing, revising of the manuscript. FH and CC participated literature searching. NP and LW helped with consultation of genetic information. XD and LY contributed to the qualitative coding and the writing of the manuscript. FY and JP developed the initial idea for this study, led the literature search, and critically reviewed manuscript drafts for intellectual content.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by the National Key Research and Development Program of China (No. 2016YFC1306202); and the National Natural Science Foundation of China (No. 81771408 and 81771409).</p>
</fn>
</fn-group>
<fn-group>
<fn id="fn01">
<label>1</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://gene.sfari.org/">https://gene.sfari.org/</ext-link>
</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adusei</surname><given-names>D. C.</given-names></name><name><surname>Pacey</surname><given-names>L. K.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Hampson</surname><given-names>D. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Early developmental alterations in GABAergic protein expression in fragile X knockout mice.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>59</volume>
<fpage>167</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2010.05.002</pub-id>
<pub-id pub-id-type="pmid">20470805</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aloisi</surname><given-names>E.</given-names></name><name><surname>Le Corf</surname><given-names>K.</given-names></name><name><surname>Dupuis</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Ginger</surname><given-names>M.</given-names></name><name><surname>Labrousse</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>8</volume>:<issue>1103</issue>. <pub-id pub-id-type="doi">10.1038/s41467-017-01191-2</pub-id>
<pub-id pub-id-type="pmid">29062097</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arons</surname><given-names>M. H.</given-names></name><name><surname>Thynne</surname><given-names>C. J.</given-names></name><name><surname>Grabrucker</surname><given-names>A. M.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Schoen</surname><given-names>M.</given-names></name><name><surname>Cheyne</surname><given-names>J. E.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>14966</fpage>–<lpage>14978</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2215-12.2012</pub-id>
<pub-id pub-id-type="pmid">23100419</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asaka</surname><given-names>Y.</given-names></name><name><surname>Jugloff</surname><given-names>D. G.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Eubanks</surname><given-names>J. H.</given-names></name><name><surname>Fitzsimonds</surname><given-names>R. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>21</volume>
<fpage>217</fpage>–<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2005.07.005</pub-id>
<pub-id pub-id-type="pmid">16087343</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerbach</surname><given-names>B. D.</given-names></name><name><surname>Osterweil</surname><given-names>E. K.</given-names></name><name><surname>Bear</surname><given-names>M. F.</given-names></name></person-group> (<year>2011</year>). <article-title>Mutations causing syndromic autism define an axis of synaptic pathophysiology.</article-title>
<source/><italic>Nature</italic>
<volume>480</volume>
<fpage>63</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1038/nature10658</pub-id>
<pub-id pub-id-type="pmid">22113615</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>Y.</given-names></name><name><surname>Qiu</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhong</surname><given-names>W.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Genetic association between SHANK2 polymorphisms and susceptibility to autism spectrum disorder.</article-title>
<source/><italic>IUBMB Life</italic>
<volume>70</volume>
<fpage>763</fpage>–<lpage>776</lpage>. <pub-id pub-id-type="doi">10.1002/iub.1876</pub-id>
<pub-id pub-id-type="pmid">29934968</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>A.</given-names></name><name><surname>Le Couteur</surname><given-names>A.</given-names></name><name><surname>Gottesman</surname><given-names>I.</given-names></name><name><surname>Bolton</surname><given-names>P.</given-names></name><name><surname>Simonoff</surname><given-names>E.</given-names></name><name><surname>Yuzda</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>Autism as a strongly genetic disorder: evidence from a British twin study.</article-title>
<source/><italic>Psychol. Med.</italic>
<volume>25</volume>
<fpage>63</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="pmid">7792363</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baio</surname><given-names>J.</given-names></name><name><surname>Wiggins</surname><given-names>L.</given-names></name><name><surname>Christensen</surname><given-names>D. L.</given-names></name><name><surname>Maenner</surname><given-names>M. J.</given-names></name><name><surname>Daniels</surname><given-names>J.</given-names></name><name><surname>Warren</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2014.</article-title>
<source/><italic>MMWR Surveill. Summ.</italic>
<volume>67</volume>
<fpage>1</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.ss6706a1</pub-id>
<pub-id pub-id-type="pmid">29701730</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balakrishnan</surname><given-names>S.</given-names></name><name><surname>Niebert</surname><given-names>M.</given-names></name><name><surname>Richter</surname><given-names>D. W.</given-names></name></person-group> (<year>2016</year>). <article-title>Rescue of cyclic AMP mediated long term potentiation impairment in the hippocampus of Mecp2 Knockout (Mecp2(-/y) ) Mice by Rolipram.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>10</volume>:<issue>15</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2016.00015</pub-id>
<pub-id pub-id-type="pmid">26869885</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>A. C.</given-names></name><name><surname>Kim</surname><given-names>M. S.</given-names></name><name><surname>Ertunc</surname><given-names>M.</given-names></name><name><surname>Adachi</surname><given-names>M.</given-names></name><name><surname>Nelson</surname><given-names>E. D.</given-names></name><name><surname>McAnally</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>105</volume>
<fpage>9391</fpage>–<lpage>9396</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0802679105</pub-id>
<pub-id pub-id-type="pmid">18599438</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barth</surname><given-names>L.</given-names></name><name><surname>Sutterlin</surname><given-names>R.</given-names></name><name><surname>Nenniger</surname><given-names>M.</given-names></name><name><surname>Vogt</surname><given-names>K. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Reduced synaptic activity in neuronal networks derived from embryonic stem cells of murine Rett syndrome model.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>8</volume>:<issue>79</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00079</pub-id>
<pub-id pub-id-type="pmid">24723848</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bateup</surname><given-names>H. S.</given-names></name><name><surname>Takasaki</surname><given-names>K. T.</given-names></name><name><surname>Saulnier</surname><given-names>J. L.</given-names></name><name><surname>Denefrio</surname><given-names>C. L.</given-names></name><name><surname>Sabatini</surname><given-names>B. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>8862</fpage>–<lpage>8869</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1617-11.2011</pub-id>
<pub-id pub-id-type="pmid">21677170</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Béïque</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>D.</given-names></name><name><surname>Kang</surname><given-names>M.</given-names></name><name><surname>Aizawa</surname><given-names>H.</given-names></name><name><surname>Takamiya</surname><given-names>K.</given-names></name><name><surname>Huganir</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Synapse-specific regulation of AMPA receptor function by PSD-95.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>19535</fpage>–<lpage>19540</lpage>.<pub-id pub-id-type="pmid">17148601</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkel</surname><given-names>S.</given-names></name><name><surname>Marshall</surname><given-names>C. R.</given-names></name><name><surname>Weiss</surname><given-names>B.</given-names></name><name><surname>Howe</surname><given-names>J.</given-names></name><name><surname>Roeth</surname><given-names>R.</given-names></name><name><surname>Moog</surname><given-names>U.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>42</volume>
<fpage>489</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1038/ng.589</pub-id>
<pub-id pub-id-type="pmid">20473310</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biederer</surname><given-names>T.</given-names></name><name><surname>Sudhof</surname><given-names>T. C.</given-names></name></person-group> (<year>2000</year>). <article-title>Mints as adaptors. Direct binding to neurexins and recruitment of munc18.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>275</volume>
<fpage>39803</fpage>–<lpage>39806</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.C000656200</pub-id>
<pub-id pub-id-type="pmid">11036064</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumberg</surname><given-names>S.</given-names></name><name><surname>Bramlett</surname><given-names>M.</given-names></name><name><surname>Kogan</surname><given-names>M.</given-names></name><name><surname>Schieve</surname><given-names>L.</given-names></name><name><surname>Jones</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011-2012.</article-title>
<source/><italic>Natl. Health Stat. Rep.</italic>
<volume>65</volume>
<fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="pmid">24988818</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blundell</surname><given-names>J.</given-names></name><name><surname>Blaiss</surname><given-names>C.</given-names></name><name><surname>Etherton</surname><given-names>M.</given-names></name><name><surname>Espinosa</surname><given-names>F.</given-names></name><name><surname>Tabuchi</surname><given-names>K.</given-names></name><name><surname>Walz</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>30</volume>
<fpage>2115</fpage>–<lpage>2129</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4517-09.2010</pub-id>
<pub-id pub-id-type="pmid">20147539</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boccuto</surname><given-names>L.</given-names></name><name><surname>Lauri</surname><given-names>M.</given-names></name><name><surname>Sarasua</surname><given-names>S. M.</given-names></name><name><surname>Skinner</surname><given-names>C. D.</given-names></name><name><surname>Buccella</surname><given-names>D.</given-names></name><name><surname>Dwivedi</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>21</volume>
<fpage>310</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2012.175</pub-id>
<pub-id pub-id-type="pmid">22892527</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Born</surname><given-names>G.</given-names></name><name><surname>Grayton</surname><given-names>H. M.</given-names></name><name><surname>Langhorst</surname><given-names>H.</given-names></name><name><surname>Dudanova</surname><given-names>I.</given-names></name><name><surname>Rohlmann</surname><given-names>A.</given-names></name><name><surname>Woodward</surname><given-names>B. W.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Genetic targeting of NRXN2 in mice unveils role in excitatory cortical synapse function and social behaviors.</article-title>
<source/><italic>Front. Synaptic Neurosci.</italic>
<volume>7</volume>:<issue>3</issue>. <pub-id pub-id-type="doi">10.3389/fnsyn.2015.00003</pub-id>
<pub-id pub-id-type="pmid">25745399</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boukhris</surname><given-names>T.</given-names></name><name><surname>Sheehy</surname><given-names>O.</given-names></name><name><surname>Mottron</surname><given-names>L.</given-names></name><name><surname>Berard</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Antidepressant use during pregnancy and the risk of autism spectrum disorder in children.</article-title>
<source/><italic>JAMA Pediatr.</italic>
<volume>170</volume>
<fpage>117</fpage>–<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2015.3356</pub-id>
<pub-id pub-id-type="pmid">26660917</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brockhaus</surname><given-names>J.</given-names></name><name><surname>Schreitmuller</surname><given-names>M.</given-names></name><name><surname>Repetto</surname><given-names>D.</given-names></name><name><surname>Klatt</surname><given-names>O.</given-names></name><name><surname>Reissner</surname><given-names>C.</given-names></name><name><surname>Elmslie</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Alpha-neurexins together with alpha2delta-1 auxiliary subunits regulate Ca(2+) influx through Cav2.1 channels.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>38</volume>
<fpage>8277</fpage>–<lpage>8294</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0511-18.2018</pub-id>
<pub-id pub-id-type="pmid">30104341</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A. S.</given-names></name><name><surname>Sourander</surname><given-names>A.</given-names></name><name><surname>Hinkka-Yli-Salomaki</surname><given-names>S.</given-names></name><name><surname>McKeague</surname><given-names>I. W.</given-names></name><name><surname>Sundvall</surname><given-names>J.</given-names></name><name><surname>Surcel</surname><given-names>H. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Elevated maternal C-reactive protein and autism in a national birth cohort.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>19</volume>
<fpage>259</fpage>–<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2012.197</pub-id>
<pub-id pub-id-type="pmid">23337946</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucan</surname><given-names>M.</given-names></name><name><surname>Abrahams</surname><given-names>B. S.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Glessner</surname><given-names>J. T.</given-names></name><name><surname>Herman</surname><given-names>E. I.</given-names></name><name><surname>Sonnenblick</surname><given-names>L. I.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>5</volume>:<issue>e1000536</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1000536</pub-id>
<pub-id pub-id-type="pmid">19557195</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Budreck</surname><given-names>E. C.</given-names></name><name><surname>Scheiffele</surname><given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>26</volume>
<fpage>1738</fpage>–<lpage>1748</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05842.x</pub-id>
<pub-id pub-id-type="pmid">17897391</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buiting</surname><given-names>K.</given-names></name><name><surname>Williams</surname><given-names>C.</given-names></name><name><surname>Horsthemke</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Angelman syndrome - insights into a rare neurogenetic disorder.</article-title>
<source/><italic>Nat. Rev. Neurol.</italic>
<volume>12</volume>
<fpage>584</fpage>–<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2016.133</pub-id>
<pub-id pub-id-type="pmid">27615419</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bustos</surname><given-names>F. J.</given-names></name><name><surname>Varela-Nallar</surname><given-names>L.</given-names></name><name><surname>Campos</surname><given-names>M.</given-names></name><name><surname>Henriquez</surname><given-names>B.</given-names></name><name><surname>Phillips</surname><given-names>M.</given-names></name><name><surname>Opazo</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>PSD95 suppresses dendritic arbor development in mature hippocampal neurons by occluding the clustering of NR2B-NMDA receptors.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e94037</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0094037</pub-id>
<pub-id pub-id-type="pmid">24705401</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>M. G.</given-names></name><name><surname>Dasouki</surname><given-names>M. J.</given-names></name><name><surname>Zhou</surname><given-names>X. P.</given-names></name><name><surname>Talebizadeh</surname><given-names>Z.</given-names></name><name><surname>Brown</surname><given-names>M.</given-names></name><name><surname>Takahashi</surname><given-names>T. N.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>42</volume>
<fpage>318</fpage>–<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2004.024646</pub-id>
<pub-id pub-id-type="pmid">15805158</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buxbaum</surname><given-names>J. D.</given-names></name><name><surname>Cai</surname><given-names>G.</given-names></name><name><surname>Chaste</surname><given-names>P.</given-names></name><name><surname>Nygren</surname><given-names>G.</given-names></name><name><surname>Goldsmith</surname><given-names>J.</given-names></name><name><surname>Reichert</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly.</article-title>
<source/><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic>
<volume>144b</volume>, <fpage>484</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30493</pub-id>
<pub-id pub-id-type="pmid">17427195</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cajigas</surname><given-names>I. J.</given-names></name><name><surname>Will</surname><given-names>T.</given-names></name><name><surname>Schuman</surname><given-names>E. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Protein homeostasis and synaptic plasticity.</article-title>
<source/><italic>EMBO J.</italic>
<volume>29</volume>
<fpage>2746</fpage>–<lpage>2752</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2010.173</pub-id>
<pub-id pub-id-type="pmid">20717144</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calfa</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Rutherford</surname><given-names>J. M.</given-names></name><name><surname>Pozzo-Miller</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Excitation/inhibition imbalance and impaired synaptic inhibition in hippocampal area CA3 of Mecp2 knockout mice.</article-title>
<source/><italic>Hippocampus</italic>
<volume>25</volume>
<fpage>159</fpage>–<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.22360</pub-id>
<pub-id pub-id-type="pmid">25209930</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camacho-Garcia</surname><given-names>R. J.</given-names></name><name><surname>Planelles</surname><given-names>M. I.</given-names></name><name><surname>Margalef</surname><given-names>M.</given-names></name><name><surname>Pecero</surname><given-names>M. L.</given-names></name><name><surname>Martinez-Leal</surname><given-names>R.</given-names></name><name><surname>Aguilera</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Mutations affecting synaptic levels of neurexin-1beta in autism and mental retardation.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>47</volume>
<fpage>135</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2012.03.031</pub-id>
<pub-id pub-id-type="pmid">22504536</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>H. T.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Samaco</surname><given-names>R. C.</given-names></name><name><surname>Xue</surname><given-names>M.</given-names></name><name><surname>Chahrour</surname><given-names>M.</given-names></name><name><surname>Yoo</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.</article-title>
<source/><italic>Nature</italic>
<volume>468</volume>
<fpage>263</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1038/nature09582</pub-id>
<pub-id pub-id-type="pmid">21068835</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>H. T.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name><name><surname>Rosenmund</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number.</article-title>
<source/><italic>Neuron</italic>
<volume>56</volume>
<fpage>58</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.08.018</pub-id>
<pub-id pub-id-type="pmid">17920015</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Nelson</surname><given-names>C. D.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Winters</surname><given-names>C. A.</given-names></name><name><surname>Azzam</surname><given-names>R.</given-names></name><name><surname>Sousa</surname><given-names>A. A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>PSD-95 is required to sustain the molecular organization of the postsynaptic density.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>6329</fpage>–<lpage>6338</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.5968-10.2011</pub-id>
<pub-id pub-id-type="pmid">21525273</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chih</surname><given-names>B.</given-names></name><name><surname>Afridi</surname><given-names>S. K.</given-names></name><name><surname>Clark</surname><given-names>L.</given-names></name><name><surname>Scheiffele</surname><given-names>P.</given-names></name></person-group> (<year>2004</year>). <article-title>Disorder-associated mutations lead to functional inactivation of neuroligins.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>13</volume>
<fpage>1471</fpage>–<lpage>1477</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh158</pub-id>
<pub-id pub-id-type="pmid">15150161</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ching</surname><given-names>M.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Tan</surname><given-names>W.</given-names></name><name><surname>Jeste</surname><given-names>S.</given-names></name><name><surname>Morrow</surname><given-names>E.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders.</article-title>
<source/><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic> 153B, <fpage>937</fpage>–<lpage>947</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.31063</pub-id>
<pub-id pub-id-type="pmid">20468056</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chmielewska</surname><given-names>J. J.</given-names></name><name><surname>Kuzniewska</surname><given-names>B.</given-names></name><name><surname>Milek</surname><given-names>J.</given-names></name><name><surname>Urbanska</surname><given-names>K.</given-names></name><name><surname>Dziembowska</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Neuroligin 1, 2, and 3 regulation at the synapse: FMRP-dependent translation and activity-induced proteolytic cleavage.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<pub-id pub-id-type="doi">10.1007/s12035-018-1243-1</pub-id> [Epub ahead of print]. <pub-id pub-id-type="pmid">30056576</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chubykin</surname><given-names>A.</given-names></name><name><surname>Atasoy</surname><given-names>D.</given-names></name><name><surname>Etherton</surname><given-names>M.</given-names></name><name><surname>Brose</surname><given-names>N.</given-names></name><name><surname>Kavalali</surname><given-names>E.</given-names></name><name><surname>Gibson</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2.</article-title>
<source/><italic>Neuron</italic>
<volume>54</volume>
<fpage>919</fpage>–<lpage>931</lpage>. <pub-id pub-id-type="pmid">17582332</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>C. J.</given-names></name><name><surname>Mercaldo</surname><given-names>V.</given-names></name><name><surname>Restivo</surname><given-names>L.</given-names></name><name><surname>Yiu</surname><given-names>A. P.</given-names></name><name><surname>Sekeres</surname><given-names>M. J.</given-names></name><name><surname>Han</surname><given-names>J. H.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>MEF2 negatively regulates learning-induced structural plasticity and memory formation.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>15</volume>
<fpage>1255</fpage>–<lpage>1264</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3189</pub-id>
<pub-id pub-id-type="pmid">22885849</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>A. L.</given-names></name><name><surname>Levenson</surname><given-names>J. M.</given-names></name><name><surname>Vilaythong</surname><given-names>A. P.</given-names></name><name><surname>Richman</surname><given-names>R.</given-names></name><name><surname>Armstrong</surname><given-names>D. L.</given-names></name><name><surname>Noebels</surname><given-names>J. L.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Mild overexpression of MeCP2 causes a progressive neurological disorder in mice.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>13</volume>
<fpage>2679</fpage>–<lpage>2689</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh282</pub-id>
<pub-id pub-id-type="pmid">15351775</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colvert</surname><given-names>E.</given-names></name><name><surname>Tick</surname><given-names>B.</given-names></name><name><surname>McEwen</surname><given-names>F.</given-names></name><name><surname>Stewart</surname><given-names>C.</given-names></name><name><surname>Curran</surname><given-names>S. R.</given-names></name><name><surname>Woodhouse</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Heritability of autism spectrum disorder in a UK population-based twin sample.</article-title>
<source/><italic>JAMA Psychiatry</italic>
<volume>72</volume>
<fpage>415</fpage>–<lpage>423</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.3028</pub-id>
<pub-id pub-id-type="pmid">25738232</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comoletti</surname><given-names>D.</given-names></name><name><surname>De Jaco</surname><given-names>A.</given-names></name><name><surname>Jennings</surname><given-names>L. L.</given-names></name><name><surname>Flynn</surname><given-names>R. E.</given-names></name><name><surname>Gaietta</surname><given-names>G.</given-names></name><name><surname>Tsigelny</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>The Arg451Cys-neuroligin-3 mutation associated with autism reveals a defect in protein processing.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>24</volume>
<fpage>4889</fpage>–<lpage>4893</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0468-04.2004</pub-id>
<pub-id pub-id-type="pmid">15152050</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>V.</given-names></name><name><surname>Aigner</surname><given-names>S.</given-names></name><name><surname>Vukcevic</surname><given-names>M.</given-names></name><name><surname>Sauter</surname><given-names>E.</given-names></name><name><surname>Behr</surname><given-names>K.</given-names></name><name><surname>Ebeling</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>mTORC1 inhibition corrects neurodevelopmental and synaptic alterations in a human stem cell model of tuberous sclerosis.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>15</volume>
<fpage>86</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.02.090</pub-id>
<pub-id pub-id-type="pmid">27052171</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cupolillo</surname><given-names>D.</given-names></name><name><surname>Hoxha</surname><given-names>E.</given-names></name><name><surname>Faralli</surname><given-names>A.</given-names></name><name><surname>De Luca</surname><given-names>A.</given-names></name><name><surname>Rossi</surname><given-names>F.</given-names></name><name><surname>Tempia</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Autistic-like traits and cerebellar dysfunction in purkinje Cell PTEN knock-out mice.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>41</volume>
<fpage>1457</fpage>–<lpage>1466</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2015.339</pub-id>
<pub-id pub-id-type="pmid">26538449</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dachtler</surname><given-names>J.</given-names></name><name><surname>Glasper</surname><given-names>J.</given-names></name><name><surname>Cohen</surname><given-names>R. N.</given-names></name><name><surname>Ivorra</surname><given-names>J. L.</given-names></name><name><surname>Swiffen</surname><given-names>D. J.</given-names></name><name><surname>Jackson</surname><given-names>A. J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Deletion of alpha-neurexin II results in autism-related behaviors in mice.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>4</volume>:<issue>e484</issue>. <pub-id pub-id-type="doi">10.1038/tp.2014.123</pub-id>
<pub-id pub-id-type="pmid">25423136</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dachtler</surname><given-names>J.</given-names></name><name><surname>Ivorra</surname><given-names>J.</given-names></name><name><surname>Rowland</surname><given-names>T.</given-names></name><name><surname>Lever</surname><given-names>C.</given-names></name><name><surname>Rodgers</surname><given-names>R.</given-names></name><name><surname>Clapcote</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Heterozygous deletion of α-neurexin I or α-neurexin II results in behaviors relevant to autism and schizophrenia.</article-title>
<source/><italic>Behav. Neurosci.</italic>
<volume>129</volume>
<fpage>765</fpage>–<lpage>776</lpage>. <pub-id pub-id-type="doi">10.1037/bne0000108</pub-id>
<pub-id pub-id-type="pmid">26595880</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahlhaus</surname><given-names>R.</given-names></name><name><surname>Hines</surname><given-names>R.</given-names></name><name><surname>Eadie</surname><given-names>B.</given-names></name><name><surname>Kannangara</surname><given-names>T.</given-names></name><name><surname>Hines</surname><given-names>D.</given-names></name><name><surname>Brown</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Overexpression of the cell adhesion protein neuroligin-1 induces learning deficits and impairs synaptic plasticity by altering the ratio of excitation to inhibition in the hippocampus.</article-title>
<source/><italic>Hippocampus</italic>
<volume>20</volume>
<fpage>305</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.20630</pub-id>
<pub-id pub-id-type="pmid">19437420</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darnell</surname><given-names>J. C.</given-names></name><name><surname>Van Driesche</surname><given-names>S. J.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Hung</surname><given-names>K. Y.</given-names></name><name><surname>Mele</surname><given-names>A.</given-names></name><name><surname>Fraser</surname><given-names>C. E.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.</article-title>
<source/><italic>Cell</italic>
<volume>146</volume>
<fpage>247</fpage>–<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.06.013</pub-id>
<pub-id pub-id-type="pmid">21784246</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>J. K.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Multifarious functions of the fragile X mental retardation protein.</article-title>
<source/><italic>Trends Genet.</italic>
<volume>33</volume>
<fpage>703</fpage>–<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1016/j.tig.2017.07.008</pub-id>
<pub-id pub-id-type="pmid">28826631</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dejanovic</surname><given-names>B.</given-names></name><name><surname>Djemie</surname><given-names>T.</given-names></name><name><surname>Grunewald</surname><given-names>N.</given-names></name><name><surname>Suls</surname><given-names>A.</given-names></name><name><surname>Kress</surname><given-names>V.</given-names></name><name><surname>Hetsch</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Simultaneous impairment of neuronal and metabolic function of mutated gephyrin in a patient with epileptic encephalopathy.</article-title>
<source/><italic>EMBO Mol. Med.</italic>
<volume>7</volume>
<fpage>1580</fpage>–<lpage>1594</lpage>. <pub-id pub-id-type="doi">10.15252/emmm.201505323</pub-id>
<pub-id pub-id-type="pmid">26613940</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dejanovic</surname><given-names>B.</given-names></name><name><surname>Lal</surname><given-names>D.</given-names></name><name><surname>Catarino</surname><given-names>C. B.</given-names></name><name><surname>Arjune</surname><given-names>S.</given-names></name><name><surname>Belaidi</surname><given-names>A. A.</given-names></name><name><surname>Trucks</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2014a</year>). <article-title>Exonic microdeletions of the gephyrin gene impair GABAergic synaptic inhibition in patients with idiopathic generalized epilepsy.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>67</volume>
<fpage>88</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.02.001</pub-id>
<pub-id pub-id-type="pmid">24561070</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dejanovic</surname><given-names>B.</given-names></name><name><surname>Schwarz</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Neuronal nitric oxide synthase-dependent S-nitrosylation of gephyrin regulates gephyrin clustering at GABAergic synapses.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>34</volume>
<fpage>7763</fpage>–<lpage>7768</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0531-14.2014</pub-id>
<pub-id pub-id-type="pmid">24899700</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dejanovic</surname><given-names>B.</given-names></name><name><surname>Semtner</surname><given-names>M.</given-names></name><name><surname>Ebert</surname><given-names>S.</given-names></name><name><surname>Lamkemeyer</surname><given-names>T.</given-names></name><name><surname>Neuser</surname><given-names>F.</given-names></name><name><surname>Luscher</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2014b</year>). <article-title>Palmitoylation of gephyrin controls receptor clustering and plasticity of GABAergic synapses.</article-title>
<source/><italic>PLoS Biol.</italic>
<volume>12</volume>:<issue>e1001908</issue>. <pub-id pub-id-type="doi">10.1371/journal.pbio.1001908</pub-id>
<pub-id pub-id-type="pmid">25025157</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doshi-Velez</surname><given-names>F.</given-names></name><name><surname>Ge</surname><given-names>Y.</given-names></name><name><surname>Kohane</surname><given-names>I.</given-names></name></person-group> (<year>2014</year>). <article-title>Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis.</article-title>
<source/><italic>Pediatrics</italic>
<volume>133</volume>
<fpage>e54</fpage>–<lpage>e63</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2013-0819</pub-id>
<pub-id pub-id-type="pmid">24323995</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>C. M.</given-names></name><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Boeckers</surname><given-names>T. M.</given-names></name><name><surname>Bockmann</surname><given-names>J.</given-names></name><name><surname>Chaste</surname><given-names>P.</given-names></name><name><surname>Fauchereau</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>39</volume>
<fpage>25</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1038/ng1933</pub-id>
<pub-id pub-id-type="pmid">17173049</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egger</surname><given-names>G.</given-names></name><name><surname>Roetzer</surname><given-names>K. M.</given-names></name><name><surname>Noor</surname><given-names>A.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Mahmood</surname><given-names>H.</given-names></name><name><surname>Schwarzbraun</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Identification of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families.</article-title>
<source/><italic>Neurogenetics</italic>
<volume>15</volume>
<fpage>117</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-014-0394-0</pub-id>
<pub-id pub-id-type="pmid">24643514</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehninger</surname><given-names>D.</given-names></name><name><surname>Han</surname><given-names>S.</given-names></name><name><surname>Shilyansky</surname><given-names>C.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Kwiatkowski</surname><given-names>D. J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>14</volume>
<fpage>843</fpage>–<lpage>848</lpage>. <pub-id pub-id-type="doi">10.1038/nm1788</pub-id>
<pub-id pub-id-type="pmid">18568033</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estes</surname><given-names>M. L.</given-names></name><name><surname>McAllister</surname><given-names>A. K.</given-names></name></person-group> (<year>2016</year>). <article-title>Maternal immune activation: implications for neuropsychiatric disorders.</article-title>
<source/><italic>Science</italic>
<volume>353</volume>
<fpage>772</fpage>–<lpage>777</lpage>. <pub-id pub-id-type="doi">10.1126/science.aag3194</pub-id>
<pub-id pub-id-type="pmid">27540164</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etherton</surname><given-names>M.</given-names></name><name><surname>Blaiss</surname><given-names>C.</given-names></name><name><surname>Powell</surname><given-names>C.</given-names></name><name><surname>Südhof</surname><given-names>T.</given-names></name></person-group> (<year>2009</year>). <article-title>Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>106</volume>
<fpage>17998</fpage>–<lpage>18003</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0910297106</pub-id>
<pub-id pub-id-type="pmid">19822762</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etherton</surname><given-names>M.</given-names></name><name><surname>Földy</surname><given-names>C.</given-names></name><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Tabuchi</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Shamloo</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011a</year>). <article-title>Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>108</volume>
<fpage>13764</fpage>–<lpage>13769</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1111093108</pub-id>
<pub-id pub-id-type="pmid">21808020</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etherton</surname><given-names>M.</given-names></name><name><surname>Tabuchi</surname><given-names>K.</given-names></name><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Ko</surname><given-names>J.</given-names></name><name><surname>Südhof</surname><given-names>T.</given-names></name></person-group> (<year>2011b</year>). <article-title>An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus.</article-title>
<source/><italic>EMBO J.</italic>
<volume>30</volume>
<fpage>2908</fpage>–<lpage>2919</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2011.182</pub-id>
<pub-id pub-id-type="pmid">21642956</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Organization and dynamics of PDZ-domain-related supramodules in the postsynaptic density.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>10</volume>
<fpage>87</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2540</pub-id>
<pub-id pub-id-type="pmid">19153575</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores</surname><given-names>C. E.</given-names></name><name><surname>Nikonenko</surname><given-names>I.</given-names></name><name><surname>Mendez</surname><given-names>P.</given-names></name><name><surname>Fritschy</surname><given-names>J. M.</given-names></name><name><surname>Tyagarajan</surname><given-names>S. K.</given-names></name><name><surname>Muller</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Activity-dependent inhibitory synapse remodeling through gephyrin phosphorylation.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>112</volume>
<fpage>E65</fpage>–<lpage>E72</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1411170112</pub-id>
<pub-id pub-id-type="pmid">25535349</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folstein</surname><given-names>S.</given-names></name><name><surname>Rutter</surname><given-names>M.</given-names></name></person-group> (<year>1977</year>). <article-title>Infantile autism: a genetic study of 21 twin pairs.</article-title>
<source/><italic>J. Child Psychol. Psychiatry</italic>
<volume>18</volume>
<fpage>297</fpage>–<lpage>321</lpage>.<pub-id pub-id-type="pmid">562353</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardener</surname><given-names>H.</given-names></name><name><surname>Spiegelman</surname><given-names>D.</given-names></name><name><surname>Buka</surname><given-names>S. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Prenatal risk factors for autism: comprehensive meta-analysis.</article-title>
<source/><italic>Br. J. Psychiatry</italic>
<volume>195</volume>
<fpage>7</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.bp.108.051672</pub-id>
<pub-id pub-id-type="pmid">19567888</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatto</surname><given-names>C. L.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models.</article-title>
<source/><italic>Front. Synaptic Neurosci.</italic>
<volume>2</volume>:<issue>4</issue>. <pub-id pub-id-type="doi">10.3389/fnsyn.2010.00004</pub-id>
<pub-id pub-id-type="pmid">21423490</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatto</surname><given-names>C. L.</given-names></name><name><surname>Pereira</surname><given-names>D.</given-names></name><name><surname>Broadie</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>GABAergic circuit dysfunction in the Drosophila Fragile X syndrome model.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>65</volume>
<fpage>142</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.01.008</pub-id>
<pub-id pub-id-type="pmid">24423648</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaugler</surname><given-names>T.</given-names></name><name><surname>Klei</surname><given-names>L.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Bodea</surname><given-names>C. A.</given-names></name><name><surname>Goldberg</surname><given-names>A. P.</given-names></name><name><surname>Lee</surname><given-names>A. B.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Most genetic risk for autism resides with common variation.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>46</volume>
<fpage>881</fpage>–<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3039</pub-id>
<pub-id pub-id-type="pmid">25038753</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Siddiqui</surname><given-names>T. J.</given-names></name><name><surname>Huashan</surname><given-names>P.</given-names></name><name><surname>Yokomaku</surname><given-names>D.</given-names></name><name><surname>Hamdan</surname><given-names>F. F.</given-names></name><name><surname>Champagne</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.</article-title>
<source/><italic>Hum. Genet.</italic>
<volume>130</volume>
<fpage>563</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-011-0975-z</pub-id>
<pub-id pub-id-type="pmid">21424692</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Spiegelman</surname><given-names>D.</given-names></name><name><surname>Piton</surname><given-names>A.</given-names></name><name><surname>Lafreniere</surname><given-names>R. G.</given-names></name><name><surname>Laurent</surname><given-names>S.</given-names></name><name><surname>St-Onge</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Novel de novo SHANK3 mutation in autistic patients.</article-title>
<source/><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic>
<volume>150b</volume>, <fpage>421</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30822</pub-id>
<pub-id pub-id-type="pmid">18615476</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>H.</given-names></name><name><surname>Auguadri</surname><given-names>L.</given-names></name><name><surname>Battaglia</surname><given-names>S.</given-names></name><name><surname>Simone Thirouin</surname><given-names>Z.</given-names></name><name><surname>Zemoura</surname><given-names>K.</given-names></name><name><surname>Messner</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Several posttranslational modifications act in concert to regulate gephyrin scaffolding and GABAergic transmission.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>7</volume>:<issue>13365</issue>. <pub-id pub-id-type="doi">10.1038/ncomms13365</pub-id>
<pub-id pub-id-type="pmid">27819299</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>J.</given-names></name><name><surname>Man</surname><given-names>H. Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Fundamental elements in autism: from neurogenesis and neurite growth to synaptic plasticity.</article-title>
<source/><italic>Front. Cell Neurosci.</italic>
<volume>11</volume>:<issue>359</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2017.00359</pub-id>
<pub-id pub-id-type="pmid">29209173</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilissen</surname><given-names>C.</given-names></name><name><surname>Hehir-Kwa</surname><given-names>J. Y.</given-names></name><name><surname>Thung</surname><given-names>D. T.</given-names></name><name><surname>van de Vorst</surname><given-names>M.</given-names></name><name><surname>van Bon</surname><given-names>B. W.</given-names></name><name><surname>Willemsen</surname><given-names>M. H.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Genome sequencing identifies major causes of severe intellectual disability.</article-title>
<source/><italic>Nature</italic>
<volume>511</volume>
<fpage>344</fpage>–<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1038/nature13394</pub-id>
<pub-id pub-id-type="pmid">24896178</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giuffrida</surname><given-names>R.</given-names></name><name><surname>Musumeci</surname><given-names>S.</given-names></name><name><surname>D’Antoni</surname><given-names>S.</given-names></name><name><surname>Bonaccorso</surname><given-names>C. M.</given-names></name><name><surname>Giuffrida-Stella</surname><given-names>A. M.</given-names></name><name><surname>Oostra</surname><given-names>B. A.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>A reduced number of metabotropic glutamate subtype 5 receptors are associated with constitutive homer proteins in a mouse model of fragile X syndrome.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>25</volume>
<fpage>8908</fpage>–<lpage>8916</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0932-05.2005</pub-id>
<pub-id pub-id-type="pmid">16192381</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glessner</surname><given-names>J. T.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Cai</surname><given-names>G.</given-names></name><name><surname>Korvatska</surname><given-names>O.</given-names></name><name><surname>Kim</surname><given-names>C. E.</given-names></name><name><surname>Wood</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Autism genome-wide copy number variation reveals ubiquitin and neuronal genes.</article-title>
<source/><italic>Nature</italic>
<volume>459</volume>
<fpage>569</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1038/nature07953</pub-id>
<pub-id pub-id-type="pmid">19404257</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenblatt</surname><given-names>E. J.</given-names></name><name><surname>Spradling</surname><given-names>A. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Fragile X mental retardation 1 gene enhances the translation of large autism-related proteins.</article-title>
<source/><italic>Science</italic>
<volume>361</volume>
<fpage>709</fpage>–<lpage>712</lpage>. <pub-id pub-id-type="doi">10.1126/science.aas9963</pub-id>
<pub-id pub-id-type="pmid">30115809</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greer</surname><given-names>P. L.</given-names></name><name><surname>Hanayama</surname><given-names>R.</given-names></name><name><surname>Bloodgood</surname><given-names>B. L.</given-names></name><name><surname>Mardinly</surname><given-names>A. R.</given-names></name><name><surname>Lipton</surname><given-names>D. M.</given-names></name><name><surname>Flavell</surname><given-names>S. W.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.</article-title>
<source/><italic>Cell</italic>
<volume>140</volume>
<fpage>704</fpage>–<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.01.026</pub-id>
<pub-id pub-id-type="pmid">20211139</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groeneweg</surname><given-names>F. L.</given-names></name><name><surname>Trattnig</surname><given-names>C.</given-names></name><name><surname>Kuhse</surname><given-names>J.</given-names></name><name><surname>Nawrotzki</surname><given-names>R. A.</given-names></name><name><surname>Kirsch</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Gephyrin: a key regulatory protein of inhibitory synapses and beyond.</article-title>
<source/><italic>Histochem. Cell Biol.</italic>
<volume>150</volume>
<fpage>489</fpage>–<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1007/s00418-018-1725-2</pub-id>
<pub-id pub-id-type="pmid">30264265</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Peng</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Xun</surname><given-names>G.</given-names></name><name><surname>Ou</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Genome-wide copy number variation analysis in a Chinese autism spectrum disorder cohort.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>44155</issue>. <pub-id pub-id-type="doi">10.1038/srep44155</pub-id>
<pub-id pub-id-type="pmid">28281572</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hackett</surname><given-names>A.</given-names></name><name><surname>Tarpey</surname><given-names>P. S.</given-names></name><name><surname>Licata</surname><given-names>A.</given-names></name><name><surname>Cox</surname><given-names>J.</given-names></name><name><surname>Whibley</surname><given-names>A.</given-names></name><name><surname>Boyle</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>18</volume>
<fpage>544</fpage>–<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2009.220</pub-id>
<pub-id pub-id-type="pmid">20029458</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname><given-names>M.</given-names></name><name><surname>Krueger-Burg</surname><given-names>D.</given-names></name><name><surname>Tuffy</surname><given-names>L. P.</given-names></name><name><surname>Cooper</surname><given-names>B. H.</given-names></name><name><surname>Taschenberger</surname><given-names>H.</given-names></name><name><surname>Goswami</surname><given-names>S. P.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Perturbed hippocampal synaptic inhibition and gamma-oscillations in a Neuroligin-4 knockout mouse model of autism.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>13</volume>
<fpage>516</fpage>–<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.09.011</pub-id>
<pub-id pub-id-type="pmid">26456829</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>K. P.</given-names></name><name><surname>Akbergenova</surname><given-names>Y.</given-names></name><name><surname>Cho</surname><given-names>R. W.</given-names></name><name><surname>Baas-Thomas</surname><given-names>M. S.</given-names></name><name><surname>Littleton</surname><given-names>J. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Shank modulates postsynaptic wnt signaling to regulate synaptic development.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>36</volume>
<fpage>5820</fpage>–<lpage>5832</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4279-15.2016</pub-id>
<pub-id pub-id-type="pmid">27225771</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hippler</surname><given-names>K.</given-names></name><name><surname>Klicpera</surname><given-names>C.</given-names></name></person-group> (<year>2003</year>). <article-title>A retrospective analysis of the clinical case records of ’autistic psychopaths’ diagnosed by Hans Asperger and his team at the University Children’s Hospital, Vienna.</article-title>
<source/><italic>Philos. Trans. R. Soc. Lond. B Biol. Sci.</italic>
<volume>358</volume>
<fpage>291</fpage>–<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1098/rstb.2002.1197</pub-id>
<pub-id pub-id-type="pmid">12639327</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobert</surname><given-names>J. A.</given-names></name><name><surname>Embacher</surname><given-names>R.</given-names></name><name><surname>Mester</surname><given-names>J. L.</given-names></name><name><surname>Frazier</surname><given-names>T. W.</given-names><suffix>II</suffix></name><name><surname>Eng</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Biochemical screening and PTEN mutation analysis in individuals with autism spectrum disorders and macrocephaly.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>22</volume>
<fpage>273</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2013.114</pub-id>
<pub-id pub-id-type="pmid">23695273</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogart</surname><given-names>A.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>LaSalle</surname><given-names>J.</given-names></name><name><surname>Schanen</surname><given-names>N.</given-names></name></person-group> (<year>2010</year>). <article-title>The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>38</volume>
<fpage>181</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2008.08.011</pub-id>
<pub-id pub-id-type="pmid">18840528</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>L.</given-names></name><name><surname>Antion</surname><given-names>M. D.</given-names></name><name><surname>Hu</surname><given-names>D.</given-names></name><name><surname>Spencer</surname><given-names>C. M.</given-names></name><name><surname>Paylor</surname><given-names>R.</given-names></name><name><surname>Klann</surname><given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression.</article-title>
<source/><italic>Neuron</italic>
<volume>51</volume>
<fpage>441</fpage>–<lpage>454</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.07.005</pub-id>
<pub-id pub-id-type="pmid">16908410</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Sathanoori</surname><given-names>M.</given-names></name><name><surname>Kochmar</surname><given-names>S.</given-names></name><name><surname>Azage</surname><given-names>M.</given-names></name><name><surname>Mann</surname><given-names>S.</given-names></name><name><surname>Madan-Khetarpal</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>A novel maternally inherited 8q24.3 and a rare paternally inherited 14q23.3 CNVs in a family with neurodevelopmental disorders.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>167a</volume>, <fpage>1921</fpage>–<lpage>1926</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.37110</pub-id>
<pub-id pub-id-type="pmid">25866352</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Stodieck</surname><given-names>S. K.</given-names></name><name><surname>Goetze</surname><given-names>B.</given-names></name><name><surname>Cui</surname><given-names>L.</given-names></name><name><surname>Wong</surname><given-names>M. H.</given-names></name><name><surname>Wenzel</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Progressive maturation of silent synapses governs the duration of a critical period.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>112</volume>
<fpage>E3131</fpage>–<lpage>E3140</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1506488112</pub-id>
<pub-id pub-id-type="pmid">26015564</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huguet</surname><given-names>G.</given-names></name><name><surname>Ey</surname><given-names>E.</given-names></name><name><surname>Bourgeron</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>The genetic landscapes of autism spectrum disorders.</article-title>
<source/><italic>Annu. Rev. Genomics Hum. Genet.</italic>
<volume>14</volume>
<fpage>191</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-genom-091212-153431</pub-id>
<pub-id pub-id-type="pmid">23875794</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hultman</surname><given-names>C. M.</given-names></name><name><surname>Sandin</surname><given-names>S.</given-names></name><name><surname>Levine</surname><given-names>S. Z.</given-names></name><name><surname>Lichtenstein</surname><given-names>P.</given-names></name><name><surname>Reichenberg</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Advancing paternal age and risk of autism: new evidence from a population-based study and a meta-analysis of epidemiological studies.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>16</volume>
<fpage>1203</fpage>–<lpage>1212</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2010.121</pub-id>
<pub-id pub-id-type="pmid">21116277</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>A. Y.</given-names></name><name><surname>Futai</surname><given-names>K.</given-names></name><name><surname>Sala</surname><given-names>C.</given-names></name><name><surname>Valtschanoff</surname><given-names>J. G.</given-names></name><name><surname>Ryu</surname><given-names>J.</given-names></name><name><surname>Woodworth</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>1697</fpage>–<lpage>1708</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3032-07.2008</pub-id>
<pub-id pub-id-type="pmid">18272690</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huttenlocher</surname><given-names>P. R.</given-names></name><name><surname>Dabholkar</surname><given-names>A. S.</given-names></name></person-group> (<year>1997</year>). <article-title>Regional differences in synaptogenesis in human cerebral cortex.</article-title>
<source/><italic>J. Comp. Neurol.</italic>
<volume>387</volume>
<fpage>167</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="pmid">9336221</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaramillo</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Pettersen</surname><given-names>A.</given-names></name><name><surname>Birnbaum</surname><given-names>S.</given-names></name><name><surname>Powell</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Autism-related neuroligin-3 mutation alters social behavior and spatial learning.</article-title>
<source/><italic>Autism Res.</italic>
<volume>7</volume>
<fpage>264</fpage>–<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1002/aur.1362</pub-id>
<pub-id pub-id-type="pmid">24619977</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y. H.</given-names></name><name><surname>Armstrong</surname><given-names>D.</given-names></name><name><surname>Albrecht</surname><given-names>U.</given-names></name><name><surname>Atkins</surname><given-names>C. M.</given-names></name><name><surname>Noebels</surname><given-names>J. L.</given-names></name><name><surname>Eichele</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.</article-title>
<source/><italic>Neuron</italic>
<volume>21</volume>
<fpage>799</fpage>–<lpage>811</lpage>. <pub-id pub-id-type="pmid">9808466</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Judson</surname><given-names>M. C.</given-names></name><name><surname>Wallace</surname><given-names>M. L.</given-names></name><name><surname>Sidorov</surname><given-names>M. S.</given-names></name><name><surname>Burette</surname><given-names>A. C.</given-names></name><name><surname>Gu</surname><given-names>B.</given-names></name><name><surname>van Woerden</surname><given-names>G. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>GABAergic neuron-specific loss of Ube3a causes angelman syndrome-like EEG abnormalities and enhances seizure susceptibility.</article-title>
<source/><italic>Neuron</italic>
<volume>90</volume>
<fpage>56</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.02.040</pub-id>
<pub-id pub-id-type="pmid">27021170</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurado</surname><given-names>S.</given-names></name><name><surname>Benoist</surname><given-names>M.</given-names></name><name><surname>Lario</surname><given-names>A.</given-names></name><name><surname>Knafo</surname><given-names>S.</given-names></name><name><surname>Petrok</surname><given-names>C. N.</given-names></name><name><surname>Esteban</surname><given-names>J. A.</given-names></name></person-group> (<year>2010</year>). <article-title>PTEN is recruited to the postsynaptic terminal for NMDA receptor-dependent long-term depression.</article-title>
<source/><italic>EMBO J.</italic>
<volume>29</volume>
<fpage>2827</fpage>–<lpage>2840</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2010.160</pub-id>
<pub-id pub-id-type="pmid">20628354</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kammermeier</surname><given-names>P. J.</given-names></name><name><surname>Worley</surname><given-names>P. F.</given-names></name></person-group> (<year>2007</year>). <article-title>Homer 1a uncouples metabotropic glutamate receptor 5 from postsynaptic effectors.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>104</volume>
<fpage>6055</fpage>–<lpage>6060</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0608991104</pub-id>
<pub-id pub-id-type="pmid">17389377</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanner</surname><given-names>L.</given-names></name></person-group> (<year>1995</year>). <article-title>[Follow-up study of eleven autistic children originally reported in 1943. 1971].</article-title>
<source/><italic>Psychiatr. Enfant</italic>
<volume>38</volume>
<fpage>421</fpage>–<lpage>461</lpage>.<pub-id pub-id-type="pmid">8657796</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaphzan</surname><given-names>H.</given-names></name><name><surname>Hernandez</surname><given-names>P.</given-names></name><name><surname>Jung</surname><given-names>J. I.</given-names></name><name><surname>Cowansage</surname><given-names>K. K.</given-names></name><name><surname>Deinhardt</surname><given-names>K.</given-names></name><name><surname>Chao</surname><given-names>M. V.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitors.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>72</volume>
<fpage>182</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2012.01.021</pub-id>
<pub-id pub-id-type="pmid">22381732</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>E.</given-names></name><name><surname>Schaeffer</surname><given-names>S. M.</given-names></name><name><surname>Dhamne</surname><given-names>S. C.</given-names></name><name><surname>Lipton</surname><given-names>J. O.</given-names></name><name><surname>Lindemann</surname><given-names>L.</given-names></name><name><surname>Honer</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>mGluR5 modulation of behavioral and epileptic phenotypes in a mouse model of tuberous sclerosis complex.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>43</volume>
<fpage>1457</fpage>–<lpage>1465</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2017.295</pub-id>
<pub-id pub-id-type="pmid">29206810</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y. S.</given-names></name><name><surname>Leventhal</surname><given-names>B. L.</given-names></name><name><surname>Koh</surname><given-names>Y. J.</given-names></name><name><surname>Fombonne</surname><given-names>E.</given-names></name><name><surname>Laska</surname><given-names>E.</given-names></name><name><surname>Lim</surname><given-names>E. C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Prevalence of autism spectrum disorders in a total population sample.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>168</volume>
<fpage>904</fpage>–<lpage>912</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2011.10101532</pub-id>
<pub-id pub-id-type="pmid">21558103</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>M. E.</given-names></name><name><surname>Monday</surname><given-names>H.</given-names></name><name><surname>Jordan</surname><given-names>B. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Proteostasis and RNA binding proteins in synaptic plasticity and in the pathogenesis of neuropsychiatric disorders.</article-title>
<source/><italic>Neural Plast.</italic>
<volume>2016</volume>:<issue>3857934</issue>. <pub-id pub-id-type="doi">10.1155/2016/3857934</pub-id>
<pub-id pub-id-type="pmid">26904297</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klusek</surname><given-names>J.</given-names></name><name><surname>Martin</surname><given-names>G. E.</given-names></name><name><surname>Losh</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Consistency between research and clinical diagnoses of autism among boys and girls with fragile X syndrome.</article-title>
<source/><italic>J. Intellect. Disabil. Res.</italic>
<volume>58</volume>
<fpage>940</fpage>–<lpage>952</lpage>. <pub-id pub-id-type="doi">10.1111/jir.12121</pub-id>
<pub-id pub-id-type="pmid">24528851</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krueger</surname><given-names>D. D.</given-names></name><name><surname>Tuffy</surname><given-names>L. P.</given-names></name><name><surname>Papadopoulos</surname><given-names>T.</given-names></name><name><surname>Brose</surname><given-names>N.</given-names></name></person-group> (<year>2012</year>). <article-title>The role of neurexins and neuroligins in the formation, maturation, and function of vertebrate synapses.</article-title>
<source/><italic>Curr. Opin. Neurobiol.</italic>
<volume>22</volume>
<fpage>412</fpage>–<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2012.02.012</pub-id>
<pub-id pub-id-type="pmid">22424845</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhnle</surname><given-names>S.</given-names></name><name><surname>Mothes</surname><given-names>B.</given-names></name><name><surname>Matentzoglu</surname><given-names>K.</given-names></name><name><surname>Scheffner</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>110</volume>
<fpage>8888</fpage>–<lpage>8893</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1302792110</pub-id>
<pub-id pub-id-type="pmid">23671107</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaSalle</surname><given-names>J. M.</given-names></name><name><surname>Reiter</surname><given-names>L. T.</given-names></name><name><surname>Chamberlain</surname><given-names>S. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.</article-title>
<source/><italic>Epigenomics</italic>
<volume>7</volume>
<fpage>1213</fpage>–<lpage>1228</lpage>. <pub-id pub-id-type="doi">10.2217/epi.15.70</pub-id>
<pub-id pub-id-type="pmid">26585570</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavelle</surname><given-names>T. A.</given-names></name><name><surname>Weinstein</surname><given-names>M. C.</given-names></name><name><surname>Newhouse</surname><given-names>J. P.</given-names></name><name><surname>Munir</surname><given-names>K.</given-names></name><name><surname>Kuhlthau</surname><given-names>K. A.</given-names></name><name><surname>Prosser</surname><given-names>L. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Economic burden of childhood autism spectrum disorders.</article-title>
<source/><italic>Pediatrics</italic>
<volume>133</volume>
<fpage>e520</fpage>–<lpage>e529</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2013-0763</pub-id>
<pub-id pub-id-type="pmid">24515505</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leblond</surname><given-names>C. S.</given-names></name><name><surname>Nava</surname><given-names>C.</given-names></name><name><surname>Polge</surname><given-names>A.</given-names></name><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Huguet</surname><given-names>G.</given-names></name><name><surname>Lumbroso</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>10</volume>:<issue>e1004580</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1004580</pub-id>
<pub-id pub-id-type="pmid">25188300</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>E.</given-names></name><name><surname>Kim</surname><given-names>R.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Park</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Shank2 deletion in parvalbumin neurons leads to moderate hyperactivity, enhanced self-grooming and suppressed seizure susceptibility in mice.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>11</volume>:<issue>209</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00209</pub-id>
<pub-id pub-id-type="pmid">29970987</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leigh</surname><given-names>J. P.</given-names></name><name><surname>Du</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Brief report: forecasting the economic burden of autism in 2015 and 2025 in the United States.</article-title>
<source/><italic>J. Autism. Dev. Disord.</italic>
<volume>45</volume>
<fpage>4135</fpage>–<lpage>4139</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-015-2521-7</pub-id>
<pub-id pub-id-type="pmid">26183723</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letellier</surname><given-names>M.</given-names></name><name><surname>Sziber</surname><given-names>Z.</given-names></name><name><surname>Chamma</surname><given-names>I.</given-names></name><name><surname>Saphy</surname><given-names>C.</given-names></name><name><surname>Papasideri</surname><given-names>I.</given-names></name><name><surname>Tessier</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>A unique intracellular tyrosine in neuroligin-1 regulates AMPA receptor recruitment during synapse differentiation and potentiation.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>9</volume>:<issue>3979</issue>. <pub-id pub-id-type="doi">10.1038/s41467-018-06220-2</pub-id>
<pub-id pub-id-type="pmid">30266896</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levinson</surname><given-names>J. N.</given-names></name><name><surname>Chery</surname><given-names>N.</given-names></name><name><surname>Huang</surname><given-names>K.</given-names></name><name><surname>Wong</surname><given-names>T. P.</given-names></name><name><surname>Gerrow</surname><given-names>K.</given-names></name><name><surname>Kang</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Neuroligins mediate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1beta in neuroligin-induced synaptic specificity.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>280</volume>
<fpage>17312</fpage>–<lpage>17319</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M413812200</pub-id>
<pub-id pub-id-type="pmid">15723836</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Pozzo-Miller</surname><given-names>L.</given-names></name></person-group> (<year>2016a</year>). <article-title>Excitatory synapses are stronger in the hippocampus of Rett syndrome mice due to altered synaptic trafficking of AMPA-type glutamate receptors.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>113</volume>
<fpage>E1575</fpage>–<lpage>E1584</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1517244113</pub-id>
<pub-id pub-id-type="pmid">26929363</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Yao</surname><given-names>A.</given-names></name><name><surname>Zhi</surname><given-names>H.</given-names></name><name><surname>Kaur</surname><given-names>K.</given-names></name><name><surname>Zhu</surname><given-names>Y. C.</given-names></name><name><surname>Jia</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016b</year>). <article-title>Angelman syndrome protein Ube3a regulates synaptic growth and endocytosis by inhibiting BMP signaling in Drosophila.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>12</volume>:<issue>e1006062</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1006062</pub-id>
<pub-id pub-id-type="pmid">27232889</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>C. S.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Yu</surname><given-names>N. K.</given-names></name><name><surname>Kang</surname><given-names>S. J.</given-names></name><name><surname>Kim</surname><given-names>T.</given-names></name><name><surname>Ko</surname><given-names>H. G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Enhancing inhibitory synaptic function reverses spatial memory deficits in Shank2 mutant mice.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>112(Pt A)</volume>, <fpage>104</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2016.08.016</pub-id>
<pub-id pub-id-type="pmid">27544825</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Vaags</surname><given-names>A. K.</given-names></name><name><surname>Sato</surname><given-names>D.</given-names></name><name><surname>Gazzellone</surname><given-names>M. J.</given-names></name><name><surname>Mitchell</surname><given-names>E. B.</given-names></name><name><surname>Chen</surname><given-names>H. Y.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>22</volume>
<fpage>2055</fpage>–<lpage>2066</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt056</pub-id>
<pub-id pub-id-type="pmid">23393157</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>F. S.</given-names></name><name><surname>Blue</surname><given-names>M. E.</given-names></name><name><surname>Erzurumlu</surname><given-names>R. S.</given-names></name></person-group> (<year>2016</year>). <article-title>Enhancement of postsynaptic GABAA and extrasynaptic NMDA receptor-mediated responses in the barrel cortex of Mecp2-null mice.</article-title>
<source/><italic>J. Neurophysiol.</italic>
<volume>115</volume>
<fpage>1298</fpage>–<lpage>1306</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00944.2015</pub-id>
<pub-id pub-id-type="pmid">26683074</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louros</surname><given-names>S. R.</given-names></name><name><surname>Osterweil</surname><given-names>E. K.</given-names></name></person-group> (<year>2016</year>). <article-title>Perturbed proteostasis in autism spectrum disorders.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>139</volume>
<fpage>1081</fpage>–<lpage>1092</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13723</pub-id>
<pub-id pub-id-type="pmid">27365114</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luikart</surname><given-names>B. W.</given-names></name><name><surname>Schnell</surname><given-names>E.</given-names></name><name><surname>Washburn</surname><given-names>E. K.</given-names></name><name><surname>Bensen</surname><given-names>A. L.</given-names></name><name><surname>Tovar</surname><given-names>K. R.</given-names></name><name><surname>Westbrook</surname><given-names>G. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Pten knockdown in vivo increases excitatory drive onto dentate granule cells.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>4345</fpage>–<lpage>4354</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0061-11.2011</pub-id>
<pub-id pub-id-type="pmid">21411674</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundbye</surname><given-names>C. J.</given-names></name><name><surname>Toft</surname><given-names>A. K. H.</given-names></name><name><surname>Banke</surname><given-names>T. G.</given-names></name></person-group> (<year>2018</year>). <article-title>Inhibition of GluN2A NMDA receptors ameliorates synaptic plasticity deficits in the Fmr1(-/y) mouse model.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>596</volume>
<fpage>5017</fpage>–<lpage>5031</lpage>. <pub-id pub-id-type="doi">10.1113/jp276304</pub-id>
<pub-id pub-id-type="pmid">30132892</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>L. Y.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>G. H.</given-names></name><name><surname>Turner</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Electrophysiological phenotypes of MeCP2 A140V mutant mouse model.</article-title>
<source/><italic>CNS Neurosci. Ther.</italic>
<volume>20</volume>
<fpage>420</fpage>–<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1111/cns.12229</pub-id>
<pub-id pub-id-type="pmid">24750778</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>W.</given-names></name><name><surname>Watanabe</surname><given-names>T.</given-names></name><name><surname>Cho</surname><given-names>S.</given-names></name><name><surname>Frost</surname><given-names>J. L.</given-names></name><name><surname>Truong</surname><given-names>T.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Shank1 regulates excitatory synaptic transmission in mouse hippocampal parvalbumin-expressing inhibitory interneurons.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>41</volume>
<fpage>1025</fpage>–<lpage>1035</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.12877</pub-id>
<pub-id pub-id-type="pmid">25816842</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>C. R.</given-names></name><name><surname>Noor</surname><given-names>A.</given-names></name><name><surname>Vincent</surname><given-names>J. B.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Feuk</surname><given-names>L.</given-names></name><name><surname>Skaug</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Structural variation of chromosomes in autism spectrum disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>82</volume>
<fpage>477</fpage>–<lpage>488</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.12.009</pub-id>
<pub-id pub-id-type="pmid">18252227</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname><given-names>K. L.</given-names></name><name><surname>Varga</surname><given-names>E. A.</given-names></name><name><surname>Pastore</surname><given-names>M. T.</given-names></name><name><surname>Prior</surname><given-names>T. W.</given-names></name><name><surname>Manickam</surname><given-names>K.</given-names></name><name><surname>Atkin</surname><given-names>J. F.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly.</article-title>
<source/><italic>Autism Res.</italic>
<volume>3</volume>
<fpage>137</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1002/aur.132</pub-id>
<pub-id pub-id-type="pmid">20533527</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meador</surname><given-names>K. J.</given-names></name><name><surname>Baker</surname><given-names>G. A.</given-names></name><name><surname>Browning</surname><given-names>N.</given-names></name><name><surname>Cohen</surname><given-names>M. J.</given-names></name><name><surname>Bromley</surname><given-names>R. L.</given-names></name><name><surname>Clayton-Smith</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>12</volume>
<fpage>244</fpage>–<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1016/s1474-4422(12)70323-x</pub-id>
<pub-id pub-id-type="pmid">23352199</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mierau</surname><given-names>S. B.</given-names></name><name><surname>Patrizi</surname><given-names>A.</given-names></name><name><surname>Hensch</surname><given-names>T. K.</given-names></name><name><surname>Fagiolini</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Cell-specific regulation of N-Methyl-D-Aspartate receptor maturation by Mecp2 in Cortical Circuits.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>79</volume>
<fpage>746</fpage>–<lpage>754</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.05.018</pub-id>
<pub-id pub-id-type="pmid">26185009</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>J. D.</given-names></name><name><surname>Iyer</surname><given-names>A. M.</given-names></name><name><surname>van Scheppingen</surname><given-names>J.</given-names></name><name><surname>Bongaarts</surname><given-names>A.</given-names></name><name><surname>Anink</surname><given-names>J. J.</given-names></name><name><surname>Janssen</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>8089</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-06145-8</pub-id>
<pub-id pub-id-type="pmid">28808237</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>R.</given-names></name><name><surname>Barton</surname><given-names>S.</given-names></name><name><surname>Harvey</surname><given-names>A. S.</given-names></name><name><surname>Williams</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Risk factors for the development of autism spectrum disorder in children with tuberous sclerosis complex: protocol for a systematic review.</article-title>
<source/><italic>Syst. Rev.</italic>
<volume>6</volume>:<issue>49</issue>. <pub-id pub-id-type="doi">10.1186/s13643-017-0448-0</pub-id>
<pub-id pub-id-type="pmid">28270230</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monaco</surname><given-names>S. A.</given-names></name><name><surname>Gulchina</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>W. J.</given-names></name></person-group> (<year>2015</year>). <article-title>NR2B subunit in the prefrontal cortex: a double-edged sword for working memory function and psychiatric disorders.</article-title>
<source/><italic>Neurosci. Biobehav. Rev.</italic>
<volume>56</volume>
<fpage>127</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2015.06.022</pub-id>
<pub-id pub-id-type="pmid">26143512</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>P.</given-names></name><name><surname>Feng</surname><given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>SHANK proteins: roles at the synapse and in autism spectrum disorder.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>18</volume>
<fpage>147</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2016.183</pub-id>
<pub-id pub-id-type="pmid">28179641</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moretti</surname><given-names>P.</given-names></name><name><surname>Levenson</surname><given-names>J. M.</given-names></name><name><surname>Battaglia</surname><given-names>F.</given-names></name><name><surname>Atkinson</surname><given-names>R.</given-names></name><name><surname>Teague</surname><given-names>R.</given-names></name><name><surname>Antalffy</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>26</volume>
<fpage>319</fpage>–<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2623-05.2006</pub-id>
<pub-id pub-id-type="pmid">16399702</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrow</surname><given-names>E. M.</given-names></name><name><surname>Yoo</surname><given-names>S. Y.</given-names></name><name><surname>Flavell</surname><given-names>S. W.</given-names></name><name><surname>Kim</surname><given-names>T. K.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Hill</surname><given-names>R. S.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Identifying autism loci and genes by tracing recent shared ancestry.</article-title>
<source/><italic>Science</italic>
<volume>321</volume>
<fpage>218</fpage>–<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1126/science.1157657</pub-id>
<pub-id pub-id-type="pmid">18621663</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moutton</surname><given-names>S.</given-names></name><name><surname>Bruel</surname><given-names>A. L.</given-names></name><name><surname>Assoum</surname><given-names>M.</given-names></name><name><surname>Chevarin</surname><given-names>M.</given-names></name><name><surname>Sarrazin</surname><given-names>E.</given-names></name><name><surname>Goizet</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Truncating variants of the DLG4 gene are responsible for intellectual disability with marfanoid features.</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>93</volume>
<fpage>1172</fpage>–<lpage>1178</lpage>. <pub-id pub-id-type="doi">10.1111/cge.13243</pub-id>
<pub-id pub-id-type="pmid">29460436</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muddashetty</surname><given-names>R. S.</given-names></name><name><surname>Nalavadi</surname><given-names>V. C.</given-names></name><name><surname>Gross</surname><given-names>C.</given-names></name><name><surname>Yao</surname><given-names>X.</given-names></name><name><surname>Xing</surname><given-names>L.</given-names></name><name><surname>Laur</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling.</article-title>
<source/><italic>Mol. Cell.</italic>
<volume>42</volume>
<fpage>673</fpage>–<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2011.05.006</pub-id>
<pub-id pub-id-type="pmid">21658607</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Na</surname><given-names>E. S.</given-names></name><name><surname>Nelson</surname><given-names>E. D.</given-names></name><name><surname>Adachi</surname><given-names>M.</given-names></name><name><surname>Autry</surname><given-names>A. E.</given-names></name><name><surname>Mahgoub</surname><given-names>M. A.</given-names></name><name><surname>Kavalali</surname><given-names>E. T.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>3109</fpage>–<lpage>3117</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.6000-11.2012</pub-id>
<pub-id pub-id-type="pmid">22378884</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najm</surname><given-names>J.</given-names></name><name><surname>Horn</surname><given-names>D.</given-names></name><name><surname>Wimplinger</surname><given-names>I.</given-names></name><name><surname>Golden</surname><given-names>J. A.</given-names></name><name><surname>Chizhikov</surname><given-names>V. V.</given-names></name><name><surname>Sudi</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>40</volume>
<fpage>1065</fpage>–<lpage>1067</lpage>. <pub-id pub-id-type="doi">10.1038/ng.194</pub-id>
<pub-id pub-id-type="pmid">19165920</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>S. B.</given-names></name><name><surname>Valakh</surname><given-names>V.</given-names></name></person-group> (<year>2015</year>). <article-title>Excitatory/inhibitory balance and circuit homeostasis in autism spectrum disorders.</article-title>
<source/><italic>Neuron</italic>
<volume>87</volume>
<fpage>684</fpage>–<lpage>698</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.07.033</pub-id>
<pub-id pub-id-type="pmid">26291155</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novara</surname><given-names>F.</given-names></name><name><surname>Beri</surname><given-names>S.</given-names></name><name><surname>Giorda</surname><given-names>R.</given-names></name><name><surname>Ortibus</surname><given-names>E.</given-names></name><name><surname>Nageshappa</surname><given-names>S.</given-names></name><name><surname>Darra</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Refining the phenotype associated with MEF2C haploinsufficiency.</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>78</volume>
<fpage>471</fpage>–<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2010.01413.x</pub-id>
<pub-id pub-id-type="pmid">20412115</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orrico</surname><given-names>A.</given-names></name><name><surname>Galli</surname><given-names>L.</given-names></name><name><surname>Buoni</surname><given-names>S.</given-names></name><name><surname>Orsi</surname><given-names>A.</given-names></name><name><surname>Vonella</surname><given-names>G.</given-names></name><name><surname>Sorrentino</surname><given-names>V.</given-names></name></person-group> (<year>2009</year>). <article-title>Novel PTEN mutations in neurodevelopmental disorders and macrocephaly.</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>75</volume>
<fpage>195</fpage>–<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2008.01074.x</pub-id>
<pub-id pub-id-type="pmid">18759867</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paciorkowski</surname><given-names>A. R.</given-names></name><name><surname>Traylor</surname><given-names>R. N.</given-names></name><name><surname>Rosenfeld</surname><given-names>J. A.</given-names></name><name><surname>Hoover</surname><given-names>J. M.</given-names></name><name><surname>Harris</surname><given-names>C. J.</given-names></name><name><surname>Winter</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways.</article-title>
<source/><italic>Neurogenetics</italic>
<volume>14</volume>
<fpage>99</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-013-0356-y</pub-id>
<pub-id pub-id-type="pmid">23389741</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pak</surname><given-names>C.</given-names></name><name><surname>Danko</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Aoto</surname><given-names>J.</given-names></name><name><surname>Anderson</surname><given-names>G.</given-names></name><name><surname>Maxeiner</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Human neuropsychiatric disease modeling using conditional deletion reveals synaptic transmission defects caused by heterozygous mutations in NRXN1.</article-title>
<source/><italic>Cell Stem Cell</italic>
<volume>17</volume>
<fpage>316</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2015.07.017</pub-id>
<pub-id pub-id-type="pmid">26279266</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikshak</surname><given-names>N. N.</given-names></name><name><surname>Luo</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>A.</given-names></name><name><surname>Won</surname><given-names>H.</given-names></name><name><surname>Lowe</surname><given-names>J. K.</given-names></name><name><surname>Chandran</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism.</article-title>
<source/><italic>Cell</italic>
<volume>155</volume>
<fpage>1008</fpage>–<lpage>1021</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.10.031</pub-id>
<pub-id pub-id-type="pmid">24267887</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastuzyn</surname><given-names>E. D.</given-names></name><name><surname>Shepherd</surname><given-names>J. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Activity-dependent arc expression and homeostatic synaptic plasticity are altered in neurons from a mouse model of angelman syndrome.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>10</volume>:<issue>234</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00234</pub-id>
<pub-id pub-id-type="pmid">28804447</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peca</surname><given-names>J.</given-names></name><name><surname>Feliciano</surname><given-names>C.</given-names></name><name><surname>Ting</surname><given-names>J. T.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Wells</surname><given-names>M. F.</given-names></name><name><surname>Venkatraman</surname><given-names>T. N.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Shank3 mutant mice display autistic-like behaviours and striatal dysfunction.</article-title>
<source/><italic>Nature</italic>
<volume>472</volume>
<fpage>437</fpage>–<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1038/nature09965</pub-id>
<pub-id pub-id-type="pmid">21423165</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrini</surname><given-names>E. M.</given-names></name><name><surname>Ravasenga</surname><given-names>T.</given-names></name><name><surname>Hausrat</surname><given-names>T. J.</given-names></name><name><surname>Iurilli</surname><given-names>G.</given-names></name><name><surname>Olcese</surname><given-names>U.</given-names></name><name><surname>Racine</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Synaptic recruitment of gephyrin regulates surface GABAA receptor dynamics for the expression of inhibitory LTP.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>5</volume>:<issue>3921</issue>. <pub-id pub-id-type="doi">10.1038/ncomms4921</pub-id>
<pub-id pub-id-type="pmid">24894704</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeiffer</surname><given-names>B. E.</given-names></name><name><surname>Zang</surname><given-names>T.</given-names></name><name><surname>Wilkerson</surname><given-names>J. R.</given-names></name><name><surname>Taniguchi</surname><given-names>M.</given-names></name><name><surname>Maksimova</surname><given-names>M. A.</given-names></name><name><surname>Smith</surname><given-names>L. N.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2.</article-title>
<source/><italic>Neuron</italic>
<volume>66</volume>
<fpage>191</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.03.017</pub-id>
<pub-id pub-id-type="pmid">20434996</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phelan</surname><given-names>K.</given-names></name><name><surname>McDermid</surname><given-names>H. E.</given-names></name></person-group> (<year>2012</year>). <article-title>The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome).</article-title>
<source/><italic>Mol. Syndromol.</italic>
<volume>2</volume>
<fpage>186</fpage>–<lpage>201</lpage>.<pub-id pub-id-type="pmid">22670140</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phelan</surname><given-names>M. C.</given-names></name><name><surname>Rogers</surname><given-names>R. C.</given-names></name><name><surname>Saul</surname><given-names>R. A.</given-names></name><name><surname>Stapleton</surname><given-names>G. A.</given-names></name><name><surname>Sweet</surname><given-names>K.</given-names></name><name><surname>McDermid</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>22q13 deletion syndrome.</article-title>
<source/><italic>Am. J. Med. Genet.</italic>
<volume>101</volume>
<fpage>91</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">11391650</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pignatelli</surname><given-names>M.</given-names></name><name><surname>Piccinin</surname><given-names>S.</given-names></name><name><surname>Molinaro</surname><given-names>G.</given-names></name><name><surname>Di Menna</surname><given-names>L.</given-names></name><name><surname>Riozzi</surname><given-names>B.</given-names></name><name><surname>Cannella</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Changes in mGlu5 receptor-dependent synaptic plasticity and coupling to homer proteins in the hippocampus of Ube3A hemizygous mice modeling angelman syndrome.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>34</volume>
<fpage>4558</fpage>–<lpage>4566</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1846-13.2014</pub-id>
<pub-id pub-id-type="pmid">24672001</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>A.</given-names></name><name><surname>Merico</surname><given-names>D.</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B.</given-names></name><name><surname>Wei</surname><given-names>J.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Sato</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>A discovery resource of rare copy number variations in individuals with autism spectrum disorder.</article-title>
<source/><italic>G3</italic>
<volume>2</volume>
<fpage>1665</fpage>–<lpage>1685</lpage>. <pub-id pub-id-type="doi">10.1534/g3.112.004689</pub-id>
<pub-id pub-id-type="pmid">23275889</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram Venkataraman</surname><given-names>G.</given-names></name><name><surname>O’Connell</surname><given-names>C.</given-names></name><name><surname>Egawa</surname><given-names>F.</given-names></name><name><surname>Kashef-Haghighi</surname><given-names>D.</given-names></name><name><surname>Wall</surname><given-names>D. P.</given-names></name></person-group> (<year>2017</year>). <article-title>De novo mutations in autism implicate the synaptic elimination network.</article-title>
<source/><italic>Pac. Symp. Biocomput.</italic>
<volume>22</volume>
<fpage>521</fpage>–<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1142/9789813207813_0048</pub-id>
<pub-id pub-id-type="pmid">27897003</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasalam</surname><given-names>A. D.</given-names></name><name><surname>Hailey</surname><given-names>H.</given-names></name><name><surname>Williams</surname><given-names>J. H.</given-names></name><name><surname>Moore</surname><given-names>S. J.</given-names></name><name><surname>Turnpenny</surname><given-names>P. D.</given-names></name><name><surname>Lloyd</surname><given-names>D. J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Characteristics of fetal anticonvulsant syndrome associated autistic disorder.</article-title>
<source/><italic>Dev. Med. Child Neurol.</italic>
<volume>47</volume>
<fpage>551</fpage>–<lpage>555</lpage>. <pub-id pub-id-type="pmid">16108456</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reissner</surname><given-names>C.</given-names></name><name><surname>Runkel</surname><given-names>F.</given-names></name><name><surname>Missler</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Neurexins.</article-title>
<source/><italic>Genome Biol.</italic>
<volume>14</volume>:<issue>213</issue>. <pub-id pub-id-type="doi">10.1186/gb-2013-14-9-213</pub-id>
<pub-id pub-id-type="pmid">24083347</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>C.</given-names></name><name><surname>Jones</surname><given-names>C.</given-names></name><name><surname>Groves</surname><given-names>L.</given-names></name><name><surname>Moss</surname><given-names>J.</given-names></name><name><surname>Oliver</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis.</article-title>
<source/><italic>Lancet Psychiatry</italic>
<volume>2</volume>
<fpage>909</fpage>–<lpage>916</lpage>. <pub-id pub-id-type="doi">10.1016/s2215-0366(15)00376-4</pub-id>
<pub-id pub-id-type="pmid">26341300</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinaldi</surname><given-names>T.</given-names></name><name><surname>Kulangara</surname><given-names>K.</given-names></name><name><surname>Antoniello</surname><given-names>K.</given-names></name><name><surname>Markram</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>104</volume>
<fpage>13501</fpage>–<lpage>13506</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0704391104</pub-id>
<pub-id pub-id-type="pmid">17675408</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritvo</surname><given-names>E. R.</given-names></name><name><surname>Freeman</surname><given-names>B. J.</given-names></name><name><surname>Mason-Brothers</surname><given-names>A.</given-names></name><name><surname>Mo</surname><given-names>A.</given-names></name><name><surname>Ritvo</surname><given-names>A. M.</given-names></name></person-group> (<year>1985</year>). <article-title>Concordance for the syndrome of autism in 40 pairs of afflicted twins.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>142</volume>
<fpage>74</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1176/ajp.142.1.74</pub-id>
<pub-id pub-id-type="pmid">4038442</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizo</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>The synaptic vesicle release machinery.</article-title>
<source/><italic>Annu. Rev. Biophys.</italic>
<volume>44</volume>
<fpage>339</fpage>–<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biophys-060414-034057</pub-id>
<pub-id pub-id-type="pmid">26098518</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>J. L.</given-names></name><name><surname>Hovanes</surname><given-names>K.</given-names></name><name><surname>Dasouki</surname><given-names>M.</given-names></name><name><surname>Manzardo</surname><given-names>A. M.</given-names></name><name><surname>Butler</surname><given-names>M. G.</given-names></name></person-group> (<year>2014</year>). <article-title>Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services.</article-title>
<source/><italic>Gene</italic>
<volume>535</volume>
<fpage>70</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2013.10.020</pub-id>
<pub-id pub-id-type="pmid">24188901</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronesi</surname><given-names>J. A.</given-names></name><name><surname>Collins</surname><given-names>K. A.</given-names></name><name><surname>Hays</surname><given-names>S. A.</given-names></name><name><surname>Tsai</surname><given-names>N. P.</given-names></name><name><surname>Guo</surname><given-names>W.</given-names></name><name><surname>Birnbaum</surname><given-names>S. G.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.</article-title>
<source/><italic>Nat. Neurosci</italic>
<volume>15</volume>
<fpage>431</fpage>–<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3033</pub-id>
<pub-id pub-id-type="pmid">22267161</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotaru</surname><given-names>D. C.</given-names></name><name><surname>van Woerden</surname><given-names>G. M.</given-names></name><name><surname>Wallaard</surname><given-names>I.</given-names></name><name><surname>Elgersma</surname><given-names>Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Adult Ube3a gene reinstatement restores the electrophysiological deficits of prefrontal cortex layer 5 neurons in a mouse model of angelman syndrome.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>38</volume>
<fpage>8011</fpage>–<lpage>8030</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0083-18.2018</pub-id>
<pub-id pub-id-type="pmid">30082419</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandin</surname><given-names>S.</given-names></name><name><surname>Hultman</surname><given-names>C. M.</given-names></name><name><surname>Kolevzon</surname><given-names>A.</given-names></name><name><surname>Gross</surname><given-names>R.</given-names></name><name><surname>MacCabe</surname><given-names>J. H.</given-names></name><name><surname>Reichenberg</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Advancing maternal age is associated with increasing risk for autism: a review and meta-analysis.</article-title>
<source/><italic>J. Am. Acad. Child Adolesc. Psychiatry</italic>
<volume>51</volume>
<fpage>477</fpage>–<lpage>486</lpage>.e471. <pub-id pub-id-type="doi">10.1016/j.jaac.2012.02.018</pub-id>
<pub-id pub-id-type="pmid">22525954</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandin</surname><given-names>S.</given-names></name><name><surname>Lichtenstein</surname><given-names>P.</given-names></name><name><surname>Kuja-Halkola</surname><given-names>R.</given-names></name><name><surname>Larsson</surname><given-names>H.</given-names></name><name><surname>Hultman</surname><given-names>C. M.</given-names></name><name><surname>Reichenberg</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>The familial risk of autism.</article-title>
<source/><italic>JAMA</italic>
<volume>311</volume>
<fpage>1770</fpage>–<lpage>1777</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2014.4144</pub-id>
<pub-id pub-id-type="pmid">24794370</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>D.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Leblond</surname><given-names>C. S.</given-names></name><name><surname>Prasad</surname><given-names>A.</given-names></name><name><surname>Pinto</surname><given-names>D.</given-names></name><name><surname>Walker</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>SHANK1 deletions in males with autism spectrum disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>90</volume>
<fpage>879</fpage>–<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.03.017</pub-id>
<pub-id pub-id-type="pmid">22503632</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmeisser</surname><given-names>M. J.</given-names></name><name><surname>Ey</surname><given-names>E.</given-names></name><name><surname>Wegener</surname><given-names>S.</given-names></name><name><surname>Bockmann</surname><given-names>J.</given-names></name><name><surname>Stempel</surname><given-names>A. V.</given-names></name><name><surname>Kuebler</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2.</article-title>
<source/><italic>Nature</italic>
<volume>486</volume>
<fpage>256</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1038/nature11015</pub-id>
<pub-id pub-id-type="pmid">22699619</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoch</surname><given-names>H.</given-names></name><name><surname>Kreibich</surname><given-names>A. S.</given-names></name><name><surname>Ferri</surname><given-names>S. L.</given-names></name><name><surname>White</surname><given-names>R. S.</given-names></name><name><surname>Bohorquez</surname><given-names>D.</given-names></name><name><surname>Banerjee</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Sociability deficits and altered amygdala circuits in mice lacking pcdh10, an autism associated gene.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>81</volume>
<fpage>193</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2016.06.008</pub-id>
<pub-id pub-id-type="pmid">27567313</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shcheglovitov</surname><given-names>A.</given-names></name><name><surname>Shcheglovitova</surname><given-names>O.</given-names></name><name><surname>Yazawa</surname><given-names>M.</given-names></name><name><surname>Portmann</surname><given-names>T.</given-names></name><name><surname>Shu</surname><given-names>R.</given-names></name><name><surname>Sebastiano</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients.</article-title>
<source/><italic>Nature</italic>
<volume>503</volume>
<fpage>267</fpage>–<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1038/nature12618</pub-id>
<pub-id pub-id-type="pmid">24132240</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverman</surname><given-names>J. L.</given-names></name><name><surname>Turner</surname><given-names>S. M.</given-names></name><name><surname>Barkan</surname><given-names>C. L.</given-names></name><name><surname>Tolu</surname><given-names>S. S.</given-names></name><name><surname>Saxena</surname><given-names>R.</given-names></name><name><surname>Hung</surname><given-names>A. Y.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Sociability and motor functions in Shank1 mutant mice.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1380</volume>
<fpage>120</fpage>–<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.026</pub-id>
<pub-id pub-id-type="pmid">20868654</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>S. E.</given-names></name><name><surname>Zhou</surname><given-names>Y. D.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Jin</surname><given-names>Z.</given-names></name><name><surname>Stoppel</surname><given-names>D. C.</given-names></name><name><surname>Anderson</surname><given-names>M. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice.</article-title>
<source/><italic>Sci. Transl. Med.</italic>
<volume>3</volume>:<issue>103ra197</issue>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3002627</pub-id>
<pub-id pub-id-type="pmid">21974935</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>J. Y.</given-names></name><name><surname>Ichtchenko</surname><given-names>K.</given-names></name><name><surname>Sudhof</surname><given-names>T. C.</given-names></name><name><surname>Brose</surname><given-names>N.</given-names></name></person-group> (<year>1999</year>). <article-title>Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>96</volume>
<fpage>1100</fpage>–<lpage>1105</lpage>.<pub-id pub-id-type="pmid">9927700</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sperow</surname><given-names>M.</given-names></name><name><surname>Berry</surname><given-names>R. B.</given-names></name><name><surname>Bayazitov</surname><given-names>I. T.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Baker</surname><given-names>S. J.</given-names></name><name><surname>Zakharenko</surname><given-names>S. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>590</volume>
<fpage>777</fpage>–<lpage>792</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2011.220236</pub-id>
<pub-id pub-id-type="pmid">22147265</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinelli</surname><given-names>L.</given-names></name><name><surname>Black</surname><given-names>F. M.</given-names></name><name><surname>Berg</surname><given-names>J. N.</given-names></name><name><surname>Eickholt</surname><given-names>B. J.</given-names></name><name><surname>Leslie</surname><given-names>N. R.</given-names></name></person-group> (<year>2015</year>). <article-title>Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>52</volume>
<fpage>128</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2014-102803</pub-id>
<pub-id pub-id-type="pmid">25527629</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefanovic</surname><given-names>S.</given-names></name><name><surname>Bassell</surname><given-names>G. J.</given-names></name><name><surname>Mihailescu</surname><given-names>M. R.</given-names></name></person-group> (<year>2015</year>). <article-title>G quadruplex RNA structures in PSD-95 mRNA: potential regulators of miR-125a seed binding site accessibility.</article-title>
<source/><italic>RNA</italic>
<volume>21</volume>
<fpage>48</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1261/rna.046722.114</pub-id>
<pub-id pub-id-type="pmid">25406362</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steffenburg</surname><given-names>S.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name><name><surname>Hellgren</surname><given-names>L.</given-names></name><name><surname>Andersson</surname><given-names>L.</given-names></name><name><surname>Gillberg</surname><given-names>I. C.</given-names></name><name><surname>Jakobsson</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>1989</year>). <article-title>A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden.</article-title>
<source/><italic>J. Child Psychol. Psychiatry</italic>
<volume>30</volume>
<fpage>405</fpage>–<lpage>416</lpage>. <pub-id pub-id-type="pmid">2745591</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stessman</surname><given-names>H. A.</given-names></name><name><surname>Xiong</surname><given-names>B.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Hoekzema</surname><given-names>K.</given-names></name><name><surname>Fenckova</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>49</volume>
<fpage>515</fpage>–<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3792</pub-id>
<pub-id pub-id-type="pmid">28191889</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudhof</surname><given-names>T. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Synaptic neurexin complexes: a molecular code for the logic of neural circuits.</article-title>
<source/><italic>Cell</italic>
<volume>171</volume>
<fpage>745</fpage>–<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.10.024</pub-id>
<pub-id pub-id-type="pmid">29100073</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Standley</surname><given-names>S.</given-names></name><name><surname>Ji</surname><given-names>A.</given-names></name><name><surname>Tunuguntla</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>UBE3A regulates synaptic plasticity and learning and memory by controlling SK2 channel endocytosis.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>12</volume>
<fpage>449</fpage>–<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.06.023</pub-id>
<pub-id pub-id-type="pmid">26166566</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundberg</surname><given-names>M.</given-names></name><name><surname>Tochitsky</surname><given-names>I.</given-names></name><name><surname>Buchholz</surname><given-names>D. E.</given-names></name><name><surname>Winden</surname><given-names>K.</given-names></name><name><surname>Kujala</surname><given-names>V.</given-names></name><name><surname>Kapur</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<pub-id pub-id-type="doi">10.1038/s41380-018-0018-4</pub-id> [Epub ahead of print]. <pub-id pub-id-type="pmid">29449635</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sungur</surname><given-names>A. O.</given-names></name><name><surname>Jochner</surname><given-names>M. C. E.</given-names></name><name><surname>Harb</surname><given-names>H.</given-names></name><name><surname>Kilic</surname><given-names>A.</given-names></name><name><surname>Garn</surname><given-names>H.</given-names></name><name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Aberrant cognitive phenotypes and altered hippocampal BDNF expression related to epigenetic modifications in mice lacking the post-synaptic scaffolding protein SHANK1: implications for autism spectrum disorder.</article-title>
<source/><italic>Hippocampus</italic>
<volume>27</volume>
<fpage>906</fpage>–<lpage>919</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.22741</pub-id>
<pub-id pub-id-type="pmid">28500650</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sungur</surname><given-names>A. O.</given-names></name><name><surname>Schwarting</surname><given-names>R. K.</given-names></name><name><surname>Wohr</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Early communication deficits in the Shank1 knockout mouse model for autism spectrum disorder: developmental aspects and effects of social context.</article-title>
<source/><italic>Autism Res.</italic>
<volume>9</volume>
<fpage>696</fpage>–<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1002/aur.1564</pub-id>
<pub-id pub-id-type="pmid">26419918</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sungur</surname><given-names>A. O.</given-names></name><name><surname>Vorckel</surname><given-names>K. J.</given-names></name><name><surname>Schwarting</surname><given-names>R. K.</given-names></name><name><surname>Wohr</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Repetitive behaviors in the Shank1 knockout mouse model for autism spectrum disorder: developmental aspects and effects of social context.</article-title>
<source/><italic>J. Neurosci. Methods</italic>
<volume>234</volume>
<fpage>92</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2014.05.003</pub-id>
<pub-id pub-id-type="pmid">24820912</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabuchi</surname><given-names>K.</given-names></name><name><surname>Blundell</surname><given-names>J.</given-names></name><name><surname>Etherton</surname><given-names>M.</given-names></name><name><surname>Hammer</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Powell</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice.</article-title>
<source/><italic>Science</italic>
<volume>318</volume>
<fpage>71</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="pmid">17823315</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taft</surname><given-names>C. E.</given-names></name><name><surname>Turrigiano</surname><given-names>G. G.</given-names></name></person-group> (<year>2014</year>). <article-title>PSD-95 promotes the stabilization of young synaptic contacts.</article-title>
<source/><italic>Philos. Trans. R. Soc. Lond. B Biol. Sci.</italic>
<volume>369</volume>:<issue>20130134</issue>. <pub-id pub-id-type="doi">10.1098/rstb.2013.0134</pub-id>
<pub-id pub-id-type="pmid">24298137</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>K.</given-names></name><name><surname>Gertner</surname><given-names>M. J.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Parada</surname><given-names>L. F.</given-names></name><name><surname>Bennett</surname><given-names>M. V.</given-names></name><name><surname>Zukin</surname><given-names>R. S.</given-names></name></person-group> (<year>2013</year>). <article-title>Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>110</volume>
<fpage>4738</fpage>–<lpage>4743</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1222803110</pub-id>
<pub-id pub-id-type="pmid">23487788</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Wan</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name><name><surname>Qin</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Fmr1 deficiency promotes age-dependent alterations in the cortical synaptic proteome.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>112</volume>
<fpage>E4697</fpage>–<lpage>E4706</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1502258112</pub-id>
<pub-id pub-id-type="pmid">26307763</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Shang</surname><given-names>S.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Loss of FMRP impaired hippocampal long-term plasticity and spatial learning in rats.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>10</volume>:<issue>269</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00269</pub-id>
<pub-id pub-id-type="pmid">28894415</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Till</surname><given-names>S. M.</given-names></name><name><surname>Asiminas</surname><given-names>A.</given-names></name><name><surname>Jackson</surname><given-names>A. D.</given-names></name><name><surname>Katsanevaki</surname><given-names>D.</given-names></name><name><surname>Barnes</surname><given-names>S. A.</given-names></name><name><surname>Osterweil</surname><given-names>E. K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Conserved hippocampal cellular pathophysiology but distinct behavioural deficits in a new rat model of FXS.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>24</volume>
<fpage>5977</fpage>–<lpage>5984</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv299</pub-id>
<pub-id pub-id-type="pmid">26243794</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toft</surname><given-names>A. K.</given-names></name><name><surname>Lundbye</surname><given-names>C. J.</given-names></name><name><surname>Banke</surname><given-names>T. G.</given-names></name></person-group> (<year>2016</year>). <article-title>Dysregulated NMDA-receptor signaling inhibits long-term depression in a mouse model of fragile X syndrome.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>36</volume>
<fpage>9817</fpage>–<lpage>9827</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3038-15.2016</pub-id>
<pub-id pub-id-type="pmid">27656021</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>N.</given-names></name><name><surname>Wilkerson</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>W.</given-names></name><name><surname>Huber</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>FMRP-dependent Mdm2 dephosphorylation is required for MEF2-induced synapse elimination.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>26</volume>
<fpage>293</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddw386</pub-id>
<pub-id pub-id-type="pmid">28025327</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>N.</given-names></name><name><surname>Wilkerson</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>W.</given-names></name><name><surname>Maksimova</surname><given-names>M.</given-names></name><name><surname>DeMartino</surname><given-names>G.</given-names></name><name><surname>Cowan</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95.</article-title>
<source/><italic>Cell</italic>
<volume>151</volume>
<fpage>1581</fpage>–<lpage>1594</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.11.040</pub-id>
<pub-id pub-id-type="pmid">23260144</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>P. T.</given-names></name><name><surname>Hull</surname><given-names>C.</given-names></name><name><surname>Chu</surname><given-names>Y.</given-names></name><name><surname>Greene-Colozzi</surname><given-names>E.</given-names></name><name><surname>Sadowski</surname><given-names>A. R.</given-names></name><name><surname>Leech</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice.</article-title>
<source/><italic>Nature</italic>
<volume>488</volume>
<fpage>647</fpage>–<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1038/nature11310</pub-id>
<pub-id pub-id-type="pmid">22763451</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuchman</surname><given-names>R.</given-names></name><name><surname>Cuccaro</surname><given-names>M.</given-names></name><name><surname>Alessandri</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Autism and epilepsy: historical perspective.</article-title>
<source/><italic>Brain Dev.</italic>
<volume>32</volume>
<fpage>709</fpage>–<lpage>718</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2010.04.008</pub-id>
<pub-id pub-id-type="pmid">20510557</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyagarajan</surname><given-names>S. K.</given-names></name><name><surname>Ghosh</surname><given-names>H.</given-names></name><name><surname>Yevenes</surname><given-names>G. E.</given-names></name><name><surname>Imanishi</surname><given-names>S. Y.</given-names></name><name><surname>Zeilhofer</surname><given-names>H. U.</given-names></name><name><surname>Gerrits</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Extracellular signal-regulated kinase and glycogen synthase kinase 3beta regulate gephyrin postsynaptic aggregation and GABAergic synaptic function in a calpain-dependent mechanism.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>288</volume>
<fpage>9634</fpage>–<lpage>9647</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.442616</pub-id>
<pub-id pub-id-type="pmid">23408424</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyagarajan</surname><given-names>S. K.</given-names></name><name><surname>Ghosh</surname><given-names>H.</given-names></name><name><surname>Yevenes</surname><given-names>G. E.</given-names></name><name><surname>Nikonenko</surname><given-names>I.</given-names></name><name><surname>Ebeling</surname><given-names>C.</given-names></name><name><surname>Schwerdel</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Regulation of GABAergic synapse formation and plasticity by GSK3beta-dependent phosphorylation of gephyrin.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>108</volume>
<fpage>379</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1011824108</pub-id>
<pub-id pub-id-type="pmid">21173228</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uddin</surname><given-names>M.</given-names></name><name><surname>Woodbury-Smith</surname><given-names>M.</given-names></name><name><surname>Chan</surname><given-names>A.</given-names></name><name><surname>Brunga</surname><given-names>L.</given-names></name><name><surname>Lamoureux</surname><given-names>S.</given-names></name><name><surname>Pellecchia</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Germline and somatic mutations in STXBP1 with diverse neurodevelopmental phenotypes.</article-title>
<source/><italic>Neurol Genet.</italic>
<volume>3</volume>:<issue>e199</issue>. <pub-id pub-id-type="doi">10.1212/nxg.0000000000000199</pub-id>
<pub-id pub-id-type="pmid">29264391</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaags</surname><given-names>A. K.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Sato</surname><given-names>D.</given-names></name><name><surname>Goodenberger</surname><given-names>M.</given-names></name><name><surname>Stein</surname><given-names>Q. P.</given-names></name><name><surname>Curran</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Rare deletions at the neurexin 3 locus in autism spectrum disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>90</volume>
<fpage>133</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.11.025</pub-id>
<pub-id pub-id-type="pmid">22209245</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Woerden</surname><given-names>G. M.</given-names></name><name><surname>Harris</surname><given-names>K. D.</given-names></name><name><surname>Hojjati</surname><given-names>M. R.</given-names></name><name><surname>Gustin</surname><given-names>R. M.</given-names></name><name><surname>Qiu</surname><given-names>S.</given-names></name><name><surname>de Avila Freire</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>10</volume>
<fpage>280</fpage>–<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1038/nn1845</pub-id>
<pub-id pub-id-type="pmid">17259980</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varga</surname><given-names>E. A.</given-names></name><name><surname>Pastore</surname><given-names>M.</given-names></name><name><surname>Prior</surname><given-names>T.</given-names></name><name><surname>Herman</surname><given-names>G. E.</given-names></name><name><surname>McBride</surname><given-names>K. L.</given-names></name></person-group> (<year>2009</year>). <article-title>The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly.</article-title>
<source/><italic>Genet. Med.</italic>
<volume>11</volume>
<fpage>111</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1097/GIM.0b013e31818fd762</pub-id>
<pub-id pub-id-type="pmid">19265751</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varoqueaux</surname><given-names>F.</given-names></name><name><surname>Aramuni</surname><given-names>G.</given-names></name><name><surname>Rawson</surname><given-names>R. L.</given-names></name><name><surname>Mohrmann</surname><given-names>R.</given-names></name><name><surname>Missler</surname><given-names>M.</given-names></name><name><surname>Gottmann</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Neuroligins determine synapse maturation and function.</article-title>
<source/><italic>Neuron</italic>
<volume>51</volume>
<fpage>741</fpage>–<lpage>754</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.09.003</pub-id>
<pub-id pub-id-type="pmid">16982420</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varoqueaux</surname><given-names>F.</given-names></name><name><surname>Jamain</surname><given-names>S.</given-names></name><name><surname>Brose</surname><given-names>N.</given-names></name></person-group> (<year>2004</year>). <article-title>Neuroligin 2 is exclusively localized to inhibitory synapses.</article-title>
<source/><italic>Eur. J. Cell Biol.</italic>
<volume>83</volume>
<fpage>449</fpage>–<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1078/0171-9335-00410</pub-id>
<pub-id pub-id-type="pmid">15540461</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vignoli</surname><given-names>A.</given-names></name><name><surname>La Briola</surname><given-names>F.</given-names></name><name><surname>Peron</surname><given-names>A.</given-names></name><name><surname>Turner</surname><given-names>K.</given-names></name><name><surname>Vannicola</surname><given-names>C.</given-names></name><name><surname>Saccani</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Autism spectrum disorder in tuberous sclerosis complex: searching for risk markers.</article-title>
<source/><italic>Orphanet J. Rare Dis.</italic>
<volume>10</volume>:<issue>154</issue>. <pub-id pub-id-type="doi">10.1186/s13023-015-0371-1</pub-id>
<pub-id pub-id-type="pmid">26631248</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von der Brelie</surname><given-names>C.</given-names></name><name><surname>Waltereit</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Beck</surname><given-names>H.</given-names></name><name><surname>Kirschstein</surname><given-names>T.</given-names></name></person-group> (<year>2006</year>). <article-title>Impaired synaptic plasticity in a rat model of tuberous sclerosis.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>23</volume>
<fpage>686</fpage>–<lpage>692</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04594.x</pub-id>
<pub-id pub-id-type="pmid">16487150</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>M. L.</given-names></name><name><surname>Burette</surname><given-names>A. C.</given-names></name><name><surname>Weinberg</surname><given-names>R. J.</given-names></name><name><surname>Philpot</surname><given-names>B. D.</given-names></name></person-group> (<year>2012</year>). <article-title>Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects.</article-title>
<source/><italic>Neuron</italic>
<volume>74</volume>
<fpage>793</fpage>–<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.036</pub-id>
<pub-id pub-id-type="pmid">22681684</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C. Y.</given-names></name><name><surname>Lin</surname><given-names>H. C.</given-names></name><name><surname>Song</surname><given-names>Y. P.</given-names></name><name><surname>Hsu</surname><given-names>Y. T.</given-names></name><name><surname>Lin</surname><given-names>S. Y.</given-names></name><name><surname>Hsu</surname><given-names>P. C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Protein kinase C-dependent growth-associated protein 43 phosphorylation regulates gephyrin aggregation at developing GABAergic synapses.</article-title>
<source/><italic>Mol. Cell. Biol.</italic>
<volume>35</volume>
<fpage>1712</fpage>–<lpage>1726</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.01332-14</pub-id>
<pub-id pub-id-type="pmid">25755278</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Shao</surname><given-names>S. S.</given-names></name><name><surname>He</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>Y. L.</given-names></name><name><surname>Kong</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Association analysis of genetic variant of rs13331 in PSD95 gene with autism spectrum disorders: a case-control study in a Chinese population.</article-title>
<source/><italic>J. Huazhong Univ. Sci. Technolog. Med. Sci.</italic>
<volume>36</volume>
<fpage>285</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1007/s11596-016-1581-z</pub-id>
<pub-id pub-id-type="pmid">27072977</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Xiong</surname><given-names>B.</given-names></name><name><surname>Stessman</surname><given-names>H. A.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>De novo genic mutations among a Chinese autism spectrum disorder cohort.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>7</volume>:<issue>13316</issue>. <pub-id pub-id-type="doi">10.1038/ncomms13316</pub-id>
<pub-id pub-id-type="pmid">27824329</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>McCoy</surname><given-names>P. A.</given-names></name><name><surname>Rodriguiz</surname><given-names>R. M.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Je</surname><given-names>H. S.</given-names></name><name><surname>Roberts</surname><given-names>A. C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>20</volume>
<fpage>3093</fpage>–<lpage>3108</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr212</pub-id>
<pub-id pub-id-type="pmid">21558424</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wegener</surname><given-names>S.</given-names></name><name><surname>Buschler</surname><given-names>A.</given-names></name><name><surname>Stempel</surname><given-names>A. V.</given-names></name><name><surname>Kang</surname><given-names>S. J.</given-names></name><name><surname>Lim</surname><given-names>C. S.</given-names></name><name><surname>Kaang</surname><given-names>B. K.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Defective synapse maturation and enhanced synaptic plasticity in Shank2 Deltaex7(-/-) Mice.</article-title>
<source/><italic>eNeuro</italic>
<volume>5</volume>:<issue>ENEURO.0398-17.2018</issue>. <pub-id pub-id-type="doi">10.1523/eneuro.0398-17.2018</pub-id>
<pub-id pub-id-type="pmid">30023428</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>S. M.</given-names></name><name><surname>McLeod</surname><given-names>F.</given-names></name><name><surname>Bailey</surname><given-names>M. E.</given-names></name><name><surname>Cobb</surname><given-names>S. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal.</article-title>
<source/><italic>Neuroscience</italic>
<volume>180</volume>
<fpage>314</fpage>–<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.01.061</pub-id>
<pub-id pub-id-type="pmid">21296130</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weston</surname><given-names>M. C.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Swann</surname><given-names>J. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>11441</fpage>–<lpage>11452</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1283-12.2012</pub-id><pub-id pub-id-type="pmid">22895726</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkerson</surname><given-names>J. R.</given-names></name><name><surname>Tsai</surname><given-names>N. P.</given-names></name><name><surname>Maksimova</surname><given-names>M. A.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Cabalo</surname><given-names>N. P.</given-names></name><name><surname>Loerwald</surname><given-names>K. W.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>A role for dendritic mGluR5-mediated local translation of Arc/Arg3.1 in MEF2-dependent synapse elimination.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>7</volume>
<fpage>1589</fpage>–<lpage>1600</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.04.035</pub-id>
<pub-id pub-id-type="pmid">24857654</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>M. R.</given-names></name><name><surname>DeSpenza</surname><given-names>T.</given-names><suffix>Jr.</suffix></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Gulledge</surname><given-names>A. T.</given-names></name><name><surname>Luikart</surname><given-names>B. W.</given-names></name></person-group> (<year>2015</year>). <article-title>Hyperactivity of newborn Pten knock-out neurons results from increased excitatory synaptic drive.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>35</volume>
<fpage>943</fpage>–<lpage>959</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3144-14.2015</pub-id>
<pub-id pub-id-type="pmid">25609613</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wohr</surname><given-names>M.</given-names></name><name><surname>Roullet</surname><given-names>F. I.</given-names></name><name><surname>Hung</surname><given-names>A. Y.</given-names></name><name><surname>Sheng</surname><given-names>M.</given-names></name><name><surname>Crawley</surname><given-names>J. N.</given-names></name></person-group> (<year>2011</year>). <article-title>Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e20631</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0020631</pub-id>
<pub-id pub-id-type="pmid">21695253</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Won</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>H. R.</given-names></name><name><surname>Gee</surname><given-names>H. Y.</given-names></name><name><surname>Mah</surname><given-names>W.</given-names></name><name><surname>Kim</surname><given-names>J. I.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function.</article-title>
<source/><italic>Nature</italic>
<volume>486</volume>
<fpage>261</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1038/nature11208</pub-id>
<pub-id pub-id-type="pmid">22699620</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Rui</surname><given-names>M.</given-names></name><name><surname>Zhuang</surname><given-names>Y.</given-names></name><name><surname>Lv</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Neurexin-Neuroligin 1 regulates synaptic morphology and functions via the WAVE regulatory complex in Drosophila neuromuscular junction.</article-title>
<source/><italic>Elife</italic>
<volume>7</volume>:<issue>e30457</issue>. <pub-id pub-id-type="doi">10.7554/eLife.30457</pub-id>
<pub-id pub-id-type="pmid">29537369</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>J.</given-names></name><name><surname>Kimura</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Ishizuka</surname><given-names>K.</given-names></name><name><surname>Kushima</surname><given-names>I.</given-names></name><name><surname>Arioka</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Resequencing and association analysis of Six PSD-95-related genes as possible susceptibility genes for schizophrenia and autism spectrum disorders.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>6</volume>:<issue>27491</issue>. <pub-id pub-id-type="doi">10.1038/srep27491</pub-id>
<pub-id pub-id-type="pmid">27271353</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Xia</surname><given-names>K.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Excessive UBE3A dosage impairs retinoic acid signaling and synaptic plasticity in autism spectrum disorders.</article-title>
<source/><italic>Cell Res.</italic>
<volume>28</volume>
<fpage>48</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2017.132</pub-id>
<pub-id pub-id-type="pmid">29076503</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y. M.</given-names></name><name><surname>Arsenault</surname><given-names>J.</given-names></name><name><surname>Bah</surname><given-names>A.</given-names></name><name><surname>Krzeminski</surname><given-names>M.</given-names></name><name><surname>Fekete</surname><given-names>A.</given-names></name><name><surname>Chao</surname><given-names>O. Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Identification of a molecular locus for normalizing dysregulated GABA release from interneurons in the Fragile X brain.</article-title>
<source/><italic>Mol. Psychiatry.</italic>
<pub-id pub-id-type="doi">10.1038/s41380-018-0240-0</pub-id> [Epub ahead of print]. <pub-id pub-id-type="pmid">30224722</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yangngam</surname><given-names>S.</given-names></name><name><surname>Plong-On</surname><given-names>O.</given-names></name><name><surname>Sripo</surname><given-names>T.</given-names></name><name><surname>Roongpraiwan</surname><given-names>R.</given-names></name><name><surname>Hansakunachai</surname><given-names>T.</given-names></name><name><surname>Wirojanan</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Mutation screening of the neurexin 1 gene in thai patients with intellectual disability and autism spectrum disorder.</article-title>
<source/><italic>Genet. Test Mol. Biomarkers</italic>
<volume>18</volume>
<fpage>510</fpage>–<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1089/gtmb.2014.0003</pub-id>
<pub-id pub-id-type="pmid">24832020</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Gusella</surname><given-names>J. F.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>A rare exonic NRXN3 deletion segregating with neurodevelopmental and neuropsychiatric conditions in a three-generation Chinese family.</article-title>
<source/><italic>Am. J. Med. Genet. B Neuropsychiatr. Genet.</italic>
<volume>177</volume>
<fpage>589</fpage>–<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32673</pub-id>
<pub-id pub-id-type="pmid">30076746</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Gaetano</surname><given-names>C. M.</given-names></name><name><surname>Williams</surname><given-names>K. R.</given-names></name><name><surname>Bassell</surname><given-names>G. J.</given-names></name><name><surname>Mihailescu</surname><given-names>M. R.</given-names></name></person-group> (<year>2014</year>). <article-title>FMRP interacts with G-quadruplex structures in the 3’-UTR of its dendritic target Shank1 mRNA.</article-title>
<source/><italic>RNA Biol.</italic>
<volume>11</volume>
<fpage>1364</fpage>–<lpage>1374</lpage>. <pub-id pub-id-type="doi">10.1080/15476286.2014.996464</pub-id>
<pub-id pub-id-type="pmid">25692235</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziats</surname><given-names>M. N.</given-names></name><name><surname>Rennert</surname><given-names>O. M.</given-names></name></person-group> (<year>2016</year>). <article-title>The evolving diagnostic and genetic landscapes of autism spectrum disorder.</article-title>
<source/><italic>Front. Genet.</italic>
<volume>7</volume>:<issue>65</issue>. <pub-id pub-id-type="doi">10.3389/fgene.2016.00065</pub-id>
<pub-id pub-id-type="pmid">27200076</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>